<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">HET</journal-id>
<journal-id journal-id-type="hwp">sphet</journal-id>
<journal-id journal-id-type="nlm-ta">Hum Exp Toxicol</journal-id>
<journal-title>Human &amp; Experimental Toxicology</journal-title>
<issn pub-type="ppub">0960-3271</issn>
<issn pub-type="epub">1477-0903</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0960327112456316</article-id>
<article-id pub-id-type="publisher-id">10.1177_0960327112456316</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Emergency Do Not Consume/Do Not Use concentrations for potassium permanganate in drinking water</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Willhite</surname>
<given-names>CC</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bhat</surname>
<given-names>VS</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ball</surname>
<given-names>GL</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>McLellan</surname>
<given-names>CJ</given-names>
</name>
<aff id="aff1-0960327112456316">NSF International, Dixboro Road, Ann Arbor, Michigan, USA</aff>
<xref ref-type="corresp" rid="corresp1-0960327112456316"/>
</contrib>
</contrib-group>
<author-notes>
<corresp id="corresp1-0960327112456316">Clifton J McLellan, NSF International, 789 Dixboro Road, PO Box 130140, Ann Arbor, Michigan 48113, USA. Email: <email>mclellan@nsf.org</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2013</year>
</pub-date>
<volume>32</volume>
<issue>3</issue>
<fpage>275</fpage>
<lpage>298</lpage>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Over the past decade, regulatory authorities and water purveyors have become increasingly concerned with accidental or intentional adulteration of municipal drinking water. Emergency response guidelines, such as the ‘Do Not Consume’ or use concentration limits derived herein, can be used to notify the public in such cases. Potassium permanganate (KMnO<sub>4</sub>) is used to control iron concentrations and to reduce the levels of nuisance materials that affect odor or taste of finished drinking water. Manganese (Mn) is recognized an essential nutrient, permanganate (MnO<sub>4</sub>
<sup>−</sup>) and manganous (Mn<sup>+2</sup>) ions are caustic, and the acute toxicity of KMnO<sub>4</sub> is defined by its oxidant/irritant properties and by the toxicity of Mn. Ingestion of small amounts (4–20 mg/kg) of aqueous KMnO<sub>4</sub> solutions that are above 200 mg/L causes gastrointestinal distress, while bolus ingestion has caused respiratory arrest following coagulative necrosis and hemorrhage in the esophagus, stomach, or liver. Dilute KMnO<sub>4</sub> solutions (1–100 mg/L) are used as a topical antiseptics and astringents, but &gt;1:5000 (200 mg/L) dilutions can irritate or discolor sensitive mucous membranes and direct skin or ocular contact with concentrated KMnO<sub>4</sub> can perforate tissues. Based on clinical experience with 200 mg/L KMnO<sub>4</sub>, a Do Not Consume concentration of 7 mg/L KMnO<sub>4</sub> (equivalent to 2 mg Mn/L) is recommended. Recognizing limited empirical data from which to calculate an ocular reference value, a skin contact ‘Do Not Use’ concentration of 30 mg Mn/L is recommended based on the skin irritation in some patients after a 10-min contact with 100 mg KMnO<sub>4</sub>/L.</p>
</abstract>
<kwd-group>
<kwd>Potassium permanganate</kwd>
<kwd>drinking water</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0960327112456316">
<title>Introduction</title>
<p>Title V of the Public Health Security and Bioterrorism Preparedness and Response Act (United States Public Law 107-188) mandated vulnerability assessments by drinking water purveyors who service more than 3300 connections. These assessments are intended to identify procedures that can be brought to bear in the event of a terrorist or other intentional attack on municipal water systems.<sup>
<xref ref-type="bibr" rid="bibr1-0960327112456316">1</xref>,<xref ref-type="bibr" rid="bibr2-0960327112456316">2</xref>
</sup> Emergency response plans can be valuable given the consequences of accidents involving gross chemical contamination of drinking water supplies.<sup>
<xref ref-type="bibr" rid="bibr3-0960327112456316">3</xref>
<xref ref-type="bibr" rid="bibr4-0960327112456316"/>
<xref ref-type="bibr" rid="bibr5-0960327112456316"/>
<xref ref-type="bibr" rid="bibr6-0960327112456316"/>
<xref ref-type="bibr" rid="bibr7-0960327112456316"/>
<xref ref-type="bibr" rid="bibr8-0960327112456316"/>
<xref ref-type="bibr" rid="bibr9-0960327112456316"/>–<xref ref-type="bibr" rid="bibr10-0960327112456316">10</xref>
</sup> The present study was conducted to define ‘Do Not Consume’ and ‘Do Not Use’ concentrations for potassium permanganate (KMnO<sub>4</sub>; measured as total manganese (Mn)) that may be used by regulatory agencies and water purveyors in emergency response plans. The Do Not Consume limit was based on ingestion toxicity and the Do Not Use limit was based on skin and mucous membrane toxicity to account for contact with KMnO<sub>4</sub> during bathing and showering.</p>
<p>Experience indicates the most likely scenarios for an emergency during which the affected water that reaches the public involve short-term (possibly once-in-a-lifetime) exposure for at least one but less than 30 days.<sup>
<xref ref-type="bibr" rid="bibr5-0960327112456316">5</xref>,<xref ref-type="bibr" rid="bibr8-0960327112456316">8</xref>
<xref ref-type="bibr" rid="bibr9-0960327112456316"/>–<xref ref-type="bibr" rid="bibr10-0960327112456316">10</xref>
</sup> Nevertheless, the first 24 h are critical in preventing adverse health effects after which time constituent levels are generally reduced by dilution unless the chemical source persists. Since utility customers can be exposed as a result of ingestion and direct skin and eye contact during bathing and showering, it is important to consider oral, dermal, and ocular contact with excessive concentrations of substances present in drinking water.</p>
<p>The present evaluation of acute oral, dermal, and ocular exposures to KMnO<sub>4</sub> is intended to aid regulatory agencies in decisions to avoid or prohibit direct human contact with unusually high concentrations of KMnO<sub>4</sub> in potable water. Carefully documented accounts of short-term (acute) human experience with reliable exposure data are preferred studies, but where those data are lacking controlled studies in laboratory mammals were evaluated. Either a lowest acute no-observed-adverse effect level (NOAEL), an acute lowest-observed-adverse-effect-level (LOAEL), or an acute benchmark dose (where possible) were the values that could be used to calculate an acute reference dose (RfD). To locate those values, the literature search strategy employed here was based on the Chemical Abstract Services Registry Number and at least one common name. The following public access databanks were searched:</p>
<list list-type="bullet">
<list-item>
<p>ChemID Plus</p>
</list-item>
<list-item>
<p>Registry of Toxic Effects of Chemical Substances (RTECS)</p>
</list-item>
<list-item>
<p>Hazardous Substances Data Bank (HSDB)</p>
</list-item>
<list-item>
<p>GENE-TOX</p>
</list-item>
<list-item>
<p>Environmental Mutagen Information Center (EMIC)</p>
</list-item>
<list-item>
<p>Developmental and Reproductive Toxicology (DART)</p>
</list-item>
<list-item>
<p>TOXLINE – Core and Special</p>
</list-item>
<list-item>
<p>TRI (Toxics Release Inventory)</p>
</list-item>
<list-item>
<p>Chemical Carcinogenesis Research Information System (CCRIS)</p>
</list-item>
<list-item>
<p>Medline (via PubMed)</p>
</list-item>
<list-item>
<p>Integrated Risk Information System (IRIS)</p>
</list-item>
<list-item>
<p>Syracuse Research Corporation Online Toxic Substance Control Act Database (TSCATS)</p>
</list-item>
</list>
<p>Reports considered most valuable are detailed and published in the peer-reviewed open literature. Case reports of acute exposures usually describe symptoms and their consequences and those accounts were noted here, but nearly all case reports were limited by small numbers of patients and a near-universal absence of dose; these difficulties preclude use of individual case reports to establish short-term Do Not Use and Do Not Consume drinking water limits. Detailed reports from short-term clinical trials and summaries of (uncontrolled, but often extensive) clinical experience with short-term exposure durations are valuable. Due to the relatively few animal data for most corrosive materials (like KMnO<sub>4</sub>), all published accounts (including reviews and summary reports) that could be located were compiled. Lethality data were collected, but derivation of public warning levels based on death was not considered health-protective; similarly, reports concerning mild sensory irritation and adverse taste, odor, or appearance of affected water were not the candidate key data. Acute studies were preferred, but repeat dose, subchronic, reproduction, and chronic duration studies can provide information on target organs and the results noted during initial exposure can be used to set or support derivation of protective short-term limits. Criteria to identify candidate key studies that document serious or irreversible adverse health consequences included: relevant route of exposure in aqueous solution, a reasonable number of subjects, concurrent controls (as available), and sufficient details to explain study design, execution, and evaluation. Although toxicity data from primary reference sources were preferred, in some instances, the older literature is such that often only summaries and secondary sources are available. Single dose or short-term kinetic studies can inform interspecies dose scaling, but no controlled acute dose kinetic study in any species with KMnO<sub>4</sub> was identified. Data from standard short-term genotoxicity and long-term bioassays for potential carcinogenicity were reviewed and where reliable studies of not more than 30 days exposure by an appropriate route demonstrate a significant genotoxic carcinogenic response in animals, short-term theoretical excess cancer risk greater than 1:10,000 (1 × 10<sup>−4</sup>) could be used in calculating short-term exposure limits. As acute toxicity studies for most large commodity materials used in water treatment were conducted decades before the advent of standard operating procedures and adoption of defined regulatory protocols, adherence to those regulations was not critical to identification of potential key studies; the limited animal and human toxicity data for KMnO<sub>4</sub> precluded rigorous consideration of statistical parameters. Given the relatively few published studies in humans and animals that met all these criteria, consistent results from different sources were important toz identification of potential key and supporting studies. Since KMnO<sub>4</sub> is corrosive at higher concentrations, its concentration-dependent relationship to water pH was integral to identification of short-term Do Not Use and Do Not Consume levels.</p>
<p>To derive the acute RfD and reference value (RfV), interspecies and intraspecies uncertainty factors were applied to LOAEL, NOAEL, or benchmark dose values. Data from clinical studies that included susceptible individuals were preferred key observations, where data on potentially sensitive groups (e.g. extremes of age, the infirm, nutritional status, those with genetic predisposition) are not available, additional intraspecies uncertainty factors may be selected by analogy to similar chemicals but usually those factors are less than 10. The concentrations for short-term notification derived here are designed to protect nearly all consumers including ‘susceptible’ individuals, but these emergency concentrations are such that people with idiosyncratic or unique (‘hypersusceptible’) conditions may not be fully protected. The acute oral RfD was used to derive the drinking water Do Not Consume limit, and the lower acute dermal RfV and the acute ocular RfV were used to derive the drinking water Do Not Use limit. Following US Environmental Protection Agency (EPA) convention when calculating a 1-day drinking water Health Advisory, the Do Not Consume limit is defined as the acute RfD (mg/kg) multiplied by the 10 kg weight of a child assumed to drink 1 L of water per day. Due to the brief duration, a relative source contribution was not applied.</p>
</sec>
<sec id="section2-0960327112456316">
<title>Chemical and physical characteristics</title>
<p>KMnO<sub>4</sub> (also known as permanganate (MnO<sub>4</sub>
<sup>−</sup>) of potash and Condy’s crystals) is the salt of manganic acid (also known as permanganic acid). The Mn found in KMnO<sub>4</sub> is present in the VII oxidation state (<xref ref-type="table" rid="table1-0960327112456316">Table 1</xref>).<sup>
<xref ref-type="bibr" rid="bibr11-0960327112456316">11</xref>
<xref ref-type="bibr" rid="bibr12-0960327112456316"/>
<xref ref-type="bibr" rid="bibr13-0960327112456316"/>
<xref ref-type="bibr" rid="bibr14-0960327112456316"/>–<xref ref-type="bibr" rid="bibr15-0960327112456316">15</xref>
</sup>
</p>
<p>To illustrate the influence of KMnO<sub>4</sub> concentration on pH, measurements of pH were taken of reagent grade KMnO<sub>4</sub> dissolved in distilled, deionized water at room temperature by the NSF laboratory (<xref ref-type="table" rid="table2-0960327112456316">Table 2</xref>).</p>
<table-wrap id="table1-0960327112456316" position="float">
<label>Table 1.</label>
<caption>
<p>Physical and chemical properties of KMnO<sub>4</sub>.</p>
</caption>
<graphic alternate-form-of="table1-0960327112456316" xlink:href="10.1177_0960327112456316-table1.tif"/>
<table>
<thead>
<tr>
<th>Property</th>
<th>Data</th>
<th>Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td>Empirical formula</td>
<td>KMnO<sub>4</sub>
</td>
<td>Windholz et al.<sup>
<xref ref-type="bibr" rid="bibr11-0960327112456316">11</xref>
</sup>
</td>
</tr>
<tr>
<td>CAS No.</td>
<td>7722-64-7</td>
<td>Lide<sup>
<xref ref-type="bibr" rid="bibr12-0960327112456316">12</xref>
</sup>
</td>
</tr>
<tr>
<td>Molecular weight</td>
<td>158.03</td>
<td>Windholz et al.<sup>
<xref ref-type="bibr" rid="bibr11-0960327112456316">11</xref>
</sup>
</td>
</tr>
<tr>
<td>Physical state and color</td>
<td>Purple to orange bronze-gray corthorhombic crystals</td>
<td>Lide<sup>
<xref ref-type="bibr" rid="bibr12-0960327112456316">12</xref>
</sup>
</td>
</tr>
<tr>
<td>Melting point (decomposes)</td>
<td>240°C</td>
<td>Windholz et al.<sup>
<xref ref-type="bibr" rid="bibr11-0960327112456316">11</xref>
</sup>
</td>
</tr>
<tr>
<td>Density at 17°C</td>
<td>2.7 g/cm<sup>3</sup>
</td>
<td>Lide<sup>
<xref ref-type="bibr" rid="bibr12-0960327112456316">12</xref>
</sup>
</td>
</tr>
<tr>
<td>Vapor pressure</td>
<td>Negligible</td>
<td>IPCS<sup>
<xref ref-type="bibr" rid="bibr13-0960327112456316">13</xref>
</sup>
</td>
</tr>
<tr>
<td>Water solubility<sup>a</sup>
</td>
<td>7.6 g/100 mL at 25°C</td>
<td>Lide<sup>
<xref ref-type="bibr" rid="bibr12-0960327112456316">12</xref>
</sup>
</td>
</tr>
<tr>
<td>
</td>
<td>6.4 g/100 mL at 20°C</td>
<td>IPCS<sup>
<xref ref-type="bibr" rid="bibr13-0960327112456316">13</xref>
</sup>
</td>
</tr>
<tr>
<td>p<italic>K</italic>
<sub>a</sub>
</td>
<td>−2.5</td>
<td>Eagleson<sup>
<xref ref-type="bibr" rid="bibr14-0960327112456316">14</xref>
</sup>
</td>
</tr>
<tr>
<td>
<italic>n</italic>-Octanol/water partition coefficient (log <italic>K</italic>
<sub>ow</sub>)</td>
<td>No data</td>
<td align="center">–</td>
</tr>
<tr>
<td>Henry’s law constant (air/water partition)</td>
<td>No data</td>
<td align="center">–</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0960327112456316">
<p>KMnO<sub>4</sub>: potassium permanganate.</p>
</fn>
<fn id="table-fn2-0960327112456316">
<p>
<sup>a</sup>The water solubility of KMnO<sub>4</sub> varies with temperature; at 0°C, a saturated 100 mL solution contains 2.75 g; at 10°C, a saturated 100 mL solution contains 4.07 g; at 40°C, a saturated 100 mL solution contains 11.13 g, and at 60°C, a saturated 100 mL solution contains 18.15 g.<sup>
<xref ref-type="bibr" rid="bibr15-0960327112456316">15</xref>
</sup> In aqueous solution, permanganic acid equilibrates with the hydrogen ions in water as follows: <disp-formula id="disp-formula6-0960327112456316">
<mml:math id="mml-disp6-0960327112456316"><mml:msubsup><mml:mrow><mml:mrow><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">O</mml:mi></mml:mrow></mml:mrow><mml:mn>4</mml:mn><mml:mo stretchy="false">−</mml:mo></mml:msubsup><mml:mo stretchy="false">+</mml:mo><mml:mn>8</mml:mn><mml:msup><mml:mrow><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow></mml:mrow><mml:mo stretchy="false">+</mml:mo></mml:msup><mml:mo stretchy="false">+</mml:mo><mml:mn>5</mml:mn><mml:msup><mml:mi>e</mml:mi><mml:mo stretchy="false">−</mml:mo></mml:msup><mml:mo stretchy="false">↔</mml:mo><mml:msup><mml:mrow><mml:mrow><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mo stretchy="false">+</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">+</mml:mo><mml:mn>4</mml:mn><mml:msub><mml:mrow><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mrow><mml:mi mathvariant="normal">O</mml:mi></mml:mrow></mml:mrow></mml:math>
<graphic alternate-form-of="disp-formula6-0960327112456316" xlink:href="10.1177_0960327112456316-eq6.tif"/>
</disp-formula>
</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table2-0960327112456316" position="float">
<label>Table 2.</label>
<caption>
<p>Influence of reagent grade KMnO<sub>4</sub> concentration on water pH.</p>
</caption>
<graphic alternate-form-of="table2-0960327112456316" xlink:href="10.1177_0960327112456316-table2.tif"/>
<table>
<thead>
<tr>
<th colspan="2" rowspan="2">KMnO<sub>4</sub> concentration (mg/L)</th>
<th colspan="3">pH</th>
</tr>
<tr>
<th colspan="3">Replicate number</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sample</td>
<td>Mn</td>
<td>1</td>
<td>2</td>
<td>3</td>
</tr>
<tr>
<td>500</td>
<td>174</td>
<td>5.60</td>
<td>5.57</td>
<td>6.02</td>
</tr>
<tr>
<td>1000</td>
<td>348</td>
<td>6.04</td>
<td>6.01</td>
<td>5.89</td>
</tr>
<tr>
<td>3000</td>
<td>1044</td>
<td>6.39</td>
<td>6.41</td>
<td>6.45</td>
</tr>
<tr>
<td>10,000</td>
<td>3481</td>
<td>7.17</td>
<td>7.01</td>
<td>6.87</td>
</tr>
<tr>
<td>30,000</td>
<td>10,443</td>
<td>8.01</td>
<td>7.84</td>
<td>7.82</td>
</tr>
<tr>
<td>100,000</td>
<td>34,810</td>
<td align="center" colspan="3">Not soluble</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0960327112456316">
<p>KMnO<sub>4</sub>: potassium permanganate.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section3-0960327112456316">
<title>Organoleptic properties</title>
<p>Dilute aqueous solutions are odorless, but are said to have a ‘sweet with astringent aftertaste’.<sup>
<xref ref-type="bibr" rid="bibr11-0960327112456316">11</xref>
</sup> A 0.01% aqueous solution has a pink cast, but higher concentrations tend toward purple. When present in water at concentration of &gt;0.05 mg/L, complaints of an ‘off-color’, turbidity, foul taste, and orange-brown to brown staining of ceramics, porcelain, utensils, skin, nails, bedding, and other textiles are associated with dissolved manganese dioxide (MnO<sub>2</sub>) increase.<sup>
<xref ref-type="bibr" rid="bibr16-0960327112456316">16</xref>
</sup> The black stains of MnO<sub>2</sub> on carpet, clothing, and porous surfaces are permanent. At elevated concentrations not only does the water have a black tint, but Mn reacts with tannins in tea, coffee, and liquor (e.g. whiskey) to produce a black sludge that precipitates, and it imparts a bittersweet to metallic taste.</p>
<p>Elevated Mn in water can promote bacterial growth to produce mats of gelantinous black-brown slime that is collect in hot water tanks, dishwasher lines and pumps, toilet tanks, and bowls. This slime sloughs off in globs and it can obstruct water distribution systems – including those used in home heating.</p>
</sec>
<sec id="section4-0960327112456316">
<title>Production and use</title>
<p>Mn ores (pyrolusite, psilomelane, cryptomelane, and manganite) are mined in Australia, Brazil, Gabon, India, and the Republic of South Africa. KMnO<sub>4</sub> is manufactured from MnO<sub>2</sub> by treatment with KOH to yield potassium manganate (K<sub>2</sub>MnO<sub>4</sub>). Electrolytic oxidation of the latter in alkali yields KMnO<sub>4</sub>.<sup>
<xref ref-type="bibr" rid="bibr15-0960327112456316">15</xref>
</sup>
</p>
<p>As a naturally-occurring element, Mn is present in groundwater as a result of contact with Mn mineral and it is present in surface waters where anaerobic decay of organic matter is active in sediment.<sup>
<xref ref-type="bibr" rid="bibr17-0960327112456316">17</xref>
</sup>
</p>
<p>More than 80% of the KMnO<sub>4</sub> produced is used in drinking water treatment and purification,<sup>
<xref ref-type="bibr" rid="bibr18-0960327112456316">18</xref>
</sup> where it is added at concentrations between 2.5 and 20 mg/L to oxidize ferric (Fe<sup>+3</sup>) iron to ferrous (Fe<sup>+2</sup>) iron and the latter precipitates as iron oxide. It is also used to control nuisance materials in water that impart adverse odor or taste.<sup>
<xref ref-type="bibr" rid="bibr19-0960327112456316">19</xref>
</sup> The MnO<sub>4</sub>
<sup>−</sup> ion has applications in bleaching waxes, resins and fats, in leather tanning, in treatment of sewage sludge,<sup>
<xref ref-type="bibr" rid="bibr20-0960327112456316">20</xref>
</sup> and in treatment of well and waste water<sup>
<xref ref-type="bibr" rid="bibr21-0960327112456316">21</xref>
<xref ref-type="bibr" rid="bibr22-0960327112456316"/>
<xref ref-type="bibr" rid="bibr23-0960327112456316"/>–<xref ref-type="bibr" rid="bibr24-0960327112456316">24</xref>
</sup> to reduce emissions of volatile organic hydrocarbons and H<sub>2</sub>S. It is a general biocide that is added at concentrations up to 4 mg/L to control fungi and algae, and it is also used to control parasites and other disease on fish.<sup>
<xref ref-type="bibr" rid="bibr25-0960327112456316">25</xref>,<xref ref-type="bibr" rid="bibr26-0960327112456316">26</xref>
</sup> One advantage to KMnO<sub>4</sub> used in drinking water treatment is the reduction in total trihalomethane levels in finished tap water. <sup>
<xref ref-type="bibr" rid="bibr27-0960327112456316">27</xref>
<xref ref-type="bibr" rid="bibr28-0960327112456316"/>
<xref ref-type="bibr" rid="bibr29-0960327112456316"/>–<xref ref-type="bibr" rid="bibr30-0960327112456316">30</xref>
</sup>
</p>
<p>In dilute aqueous solution (e.g. 1:10,000 or 100 mg/L) KMnO<sub>4</sub> is used as a topical antiseptic and astringent where that activity is associated with the reduction in MnO<sub>4</sub>
<sup>−</sup> to manganous (Mn<sup>+2</sup>) ion.<sup>
<xref ref-type="bibr" rid="bibr11-0960327112456316">11</xref>
</sup> A deep-purple solution was used during the late 19th and early 20th Century to treat acute gonorrheal urethritis wherein 1:5000 (200 mg/L) or 1:2000 (500 mg/L) dilutions were used to irrigate the anterior urethra over several weeks. These procedures resulted in ‘slight’ mucosal irritation,<sup>
<xref ref-type="bibr" rid="bibr31-0960327112456316">31</xref>
</sup> but solutions at 1:500 (2000 mg/L) to 1:100 (10,000 mg/L) have also been used.<sup>
<xref ref-type="bibr" rid="bibr32-0960327112456316">32</xref>
</sup> In addition, a wet dressing or bath with a 0.01% (1000 mg/L) solution or a localized treatment with a 1.0% solution (10,000 mg/L) is used topically to treat infected eczema, kill ringworms, to treat <italic>tinea pedis</italic>, <italic>tinea cruris</italic>, and reduce local skin reactions to poison ivy and snakebite.<sup>
<xref ref-type="bibr" rid="bibr33-0960327112456316">33</xref>
</sup> Dilute solutions (e.g. 1:10,000 or 100 mg/L) are also used in direct soak application (10–15 min/day) for treatment of weeping eczema and leg ulcers, but this practice is contraindicated in people with dry skin conditions where prolonged contact can cause chemical burns.<sup>
<xref ref-type="bibr" rid="bibr34-0960327112456316">34</xref>,<xref ref-type="bibr" rid="bibr35-0960327112456316">35</xref>
</sup>
</p>
<p>KMnO<sub>4</sub> is Generally Regarded as Safe (GRAS) by the US Food and Drug Administration for use in food starch at concentrations ≤0.2%, where residual Mn may not exceed 50 ppm (21 CFR 172.892), as a component of food packaging adhesives (21 CFR 175.105) and in sanitizing solutions used on food-processing equipment and utensils as well as in sanitizing solutions used on food contact surfaces in public eating establishments (21 CFR 178.1010).</p>
</sec>
<sec id="section5-0960327112456316">
<title>Hazard assessment</title>
<sec id="section6-0960327112456316">
<title>Effects on humans</title>
<sec id="section7-0960327112456316">
<title>Ingestion</title>
<p>The toxicology of Mn<sup><xref ref-type="bibr" rid="bibr36-0960327112456316">36</xref></sup>
<sup>–</sup>
<sup><xref ref-type="bibr" rid="bibr38-0960327112456316">38</xref></sup> and that of the MnO<sub>4</sub>
<sup>−</sup> ion has been reviewed.<sup><xref ref-type="bibr" rid="bibr39-0960327112456316">39</xref></sup>
<sup>,</sup>
<sup><xref ref-type="bibr" rid="bibr40-0960327112456316">40</xref></sup> Numerous reports of acute accidental or suicidal KMnO<sub>4</sub> ingestion have appeared<sup><xref ref-type="bibr" rid="bibr41-0960327112456316">41</xref></sup>
<sup>–</sup>
<sup><xref ref-type="bibr" rid="bibr50-0960327112456316">50</xref></sup> and sufficiently high oral doses (~25 g) can be abortifacient.<sup><xref ref-type="bibr" rid="bibr51-0960327112456316">51</xref></sup> Gawarammana et al.<sup><xref ref-type="bibr" rid="bibr52-0960327112456316">52</xref></sup> found that a single oral dose of 1200 mg KMnO<sub>4</sub> (either as the crystal or dissolved in an unknown quantity of water) consumed by 13 suicidal adults (ages 19–37 years) caused epigastric pain, nausea, and vomiting in 73%; there were no fatalities or any indication of laryngeal edema. Death (often within 1 h) after ingestion of concentrated KMnO<sub>4</sub> results from acute coagulative necrosis, mucosal ulceration, edema of the glottis, and asphyxiation.<sup><xref ref-type="bibr" rid="bibr53-0960327112456316">53</xref></sup>
<sup>–</sup>
<sup><xref ref-type="bibr" rid="bibr57-0960327112456316">57</xref></sup> Initial signs generally include black-brown stains in the mouth, inflammation of the oral mucosa, restlessness, and a low-grade fever; methemoglobinemia and severe hemorrhagic pancreatitis have been reported after ingestion of concentrated solutions.<sup><xref ref-type="bibr" rid="bibr40-0960327112456316">40</xref></sup>
<sup>,</sup>
<sup><xref ref-type="bibr" rid="bibr45-0960327112456316">45</xref></sup>
<sup>,</sup>
<sup><xref ref-type="bibr" rid="bibr58-0960327112456316">58</xref></sup> Fatalities after ingestion (usually more than 10 g) of concentrated KMnO<sub>4</sub> have also been attributed to hepatic necrosis and progressive cardiovascular collapse<sup><xref ref-type="bibr" rid="bibr45-0960327112456316">45</xref></sup>
<sup>,</sup>
<sup><xref ref-type="bibr" rid="bibr55-0960327112456316">55</xref></sup>
<sup>–</sup>
<sup><xref ref-type="bibr" rid="bibr57-0960327112456316">57</xref></sup>; autopsy revealed fatty degeneration and necrosis in the liver, hemorrhage into the subcortical and papillary regions of the kidney, and elevated serum Mn (756–1629 µmol/L).<sup><xref ref-type="bibr" rid="bibr59-0960327112456316">59</xref></sup>
<sup>–</sup>
<sup><xref ref-type="bibr" rid="bibr61-0960327112456316">61</xref></sup>
</p>
<p>Oral KMnO<sub>4</sub> has been used to combat acute oral opiate intoxication; to some extent, outcome appears to depend on whether the person was fed or fasted and the quantity of morphine or opium consumed.<sup><xref ref-type="bibr" rid="bibr62-0960327112456316">62</xref></sup>
<sup>–</sup>
<sup><xref ref-type="bibr" rid="bibr64-0960327112456316">64</xref></sup> Raw<sup><xref ref-type="bibr" rid="bibr62-0960327112456316">62</xref></sup> treated three women and one man with dram (11 mL) quantities of Condy’s fluid dissolved in one pint of water (~330 mg/550 mL or 600 mg/L KMnO<sub>4</sub>) by repeated gastric lavage every hour for 3–4 h. There were no adverse effects attributed to KMnO<sub>4</sub> at ~22–28 mg/kg over 4–5 h, but the man died of acute opium-induced respiratory arrest. Luff<sup><xref ref-type="bibr" rid="bibr63-0960327112456316">63</xref></sup> referenced 35 patients treated with KMnO<sub>4</sub> in water at a pH-adjusted doses of 4–10 grains (1 grain = 0.0648 g) or 260–650 mg, and Maynard<sup><xref ref-type="bibr" rid="bibr64-0960327112456316">64</xref></sup> described 19 adult males and females treated with repeated KMnO<sub>4</sub> gastric lavage. Luff<sup><xref ref-type="bibr" rid="bibr63-0960327112456316">63</xref></sup> recommended ‘8 or 10 grains of KMnO<sub>4</sub> dissolved in water should be administered at once and repeated at intervals of 30 sec once or twice’ to be followed by ‘a weak solution of the antidote about 1 grain to a tumblerful of water should be administered by mouth from time to time even after all the opium or morphine in the stomach is supposed to have been rendered inert’. Patient outcomes varied, but five grains (320 mg) dissolved in one cup (~8 ounces or 237 mL equivalent to 1350 mg/L) of water given to an adult (4.6 mg/kg apparently on an empty stomach) caused local irritation, inflammation and vomiting at 30 min after each dose. Consumption of 4 or 8 grains (up to 520 mg or 7.5 mg/kg of a 2200-mg/L aqueous solution) on a full stomach elicited no acute adverse effect.<sup><xref ref-type="bibr" rid="bibr63-0960327112456316">63</xref></sup>
</p>
<p>Ingestion of dilute KMnO<sub>4</sub> solutions is benign and presents with mild local irritation of the mouth that is often self-limiting; spontaneous emesis or diarrhea may result if a large volume is ingested.<sup><xref ref-type="bibr" rid="bibr40-0960327112456316">40</xref></sup> In a study with 171 adult male and 88 adult female patients (36.9 ± 16.2 years) hospitalized in an intensive care unit, participants received oral cleansing with 10 mL of a 0.01% (100 mg/L) KMnO<sub>4</sub> solution twice daily.<sup><xref ref-type="bibr" rid="bibr65-0960327112456316">65</xref></sup> Inspection of their oral cavity, palate, buccal spaces, posterior pharyngeal wall, and hypopharynx every 12 h made no mention of objective signs of irritation. While assessment of local oral irritation was not a specific objective of the Panchabhai et al. protocol,<sup><xref ref-type="bibr" rid="bibr65-0960327112456316">65</xref></sup> routine use of KMnO<sub>4</sub> as an oral antiseptic points to the conclusion that critically ill patients tolerate repeated dilute oral KMnO<sub>4</sub> solutions without adverse effects.</p>
<p>Repeated ingestion (125 mL of 8% KMnO<sub>4</sub> (80,000 mg/L) solution for a total dose of 10 g over 4 weeks) by an adult male induced manganism and classical signs (similar to those of Parkinsonism) were evident at 9 months. The first signs of psychological disturbance were evident within 2 weeks of the initial exposure.<sup><xref ref-type="bibr" rid="bibr66-0960327112456316">66</xref></sup> In a similar case, an 80-year-old man presented with polyneuropathy and elevated hair Mn at 14 years after he accidentally ingested KMnO<sub>4</sub> over a 4-week-period.<sup><xref ref-type="bibr" rid="bibr67-0960327112456316">67</xref></sup> Manganism presents first as mania, increased libido, insomnia, and emotional liability and it then progresses to incoordination and fatigue and finally (in some cases many years after cessation of exposure) to involuntary, irregular muscle contractions (particularly noticeable upon walking) and skeletal muscle hyperflexion. The prolonged time course of the disease is a consequence of the slow rate of Mn uptake into and elimination from the brain. Although the clinical signs of manganism share some of the features of Parkinsonism, the neuropathology,<sup><xref ref-type="bibr" rid="bibr68-0960327112456316">68</xref></sup> time course, therapeutic response, and lack of Mn accumulation in the brain of patients with Parkinsonism indicate manganism and idiopathic Parkinsonism have different etiologies.<sup><xref ref-type="bibr" rid="bibr69-0960327112456316">69</xref></sup>
<sup>–</sup>
<sup><xref ref-type="bibr" rid="bibr71-0960327112456316">71</xref></sup>
</p>
<p>Humans and other mammals adapt to increased Mn consumption by reducing gastrointestinal uptake and increasing biliary and pancreatic elimination (reviewed in Santamaria and Sulsky<sup><xref ref-type="bibr" rid="bibr72-0960327112456316">72</xref></sup>). Although prolonged daily ingestion of Mn salts can increase serum Mn significantly, healthy men and women tolerate repeated ingestion (60–124 days) of comparatively high Mn daily supplements (0.25–0.33 mg Mn/kg) without any discernible adverse effects<sup><xref ref-type="bibr" rid="bibr73-0960327112456316">73</xref></sup>
<sup>,</sup>
<sup><xref ref-type="bibr" rid="bibr74-0960327112456316">74</xref></sup> – including those on hematocrit, serum ferritin, serum transferrin, or serum iron in women<sup><xref ref-type="bibr" rid="bibr73-0960327112456316">73</xref></sup> and performance on neurological tests.<sup><xref ref-type="bibr" rid="bibr75-0960327112456316">75</xref></sup> The only change in note was an increase in the activity of lymphocyte superoxide dismutase after prolonged daily Mn supplementation (e.g. 89 days).<sup><xref ref-type="bibr" rid="bibr73-0960327112456316">73</xref></sup>
</p>
<p>Kawamura et al.<sup><xref ref-type="bibr" rid="bibr76-0960327112456316">76</xref></sup> recounted the experience of six Japanese families (some 25 people) who consumed manganese tetroxide (Mn<sub>3</sub>O<sub>4</sub>)-contaminated well water. All the members of the affected family developed manganism and at least two of the victims died. While the Agency for Toxic Substances and Disease Registry (ATSDR)<sup><xref ref-type="bibr" rid="bibr36-0960327112456316">36</xref></sup> concluded that all these people were exposed to elevated Mn in their drinking water; ATSDR<sup><xref ref-type="bibr" rid="bibr36-0960327112456316">36</xref></sup> questioned whether all the features described by Kawamura and associates<sup><xref ref-type="bibr" rid="bibr76-0960327112456316">76</xref></sup> were attributable to Mn given the rapid onset of the disease; the US EPA<sup><xref ref-type="bibr" rid="bibr77-0960327112456316">77</xref></sup> noted that some aspects of that description were inconsistent with clinical manganism. First, the onset of signs was rapid (2–3 weeks) and death occurred within 3 days. Second, some of the survivors recovered prior to reductions in Mn concentrations in their drinking water. The National Research Council (NRC)<sup><xref ref-type="bibr" rid="bibr38-0960327112456316">38</xref></sup> stated that the well water contained 14 ppm Mn<sub>3</sub>O<sub>4</sub> (7420 µg Mn/L) and calculated the daily dose as 20 mg Mn/day.</p>
<p>Kondakis et al.<sup><xref ref-type="bibr" rid="bibr78-0960327112456316">78</xref></sup> used 30 different weighted measures (shown to have value in diagnosis of Parkinsonism) and examined older residents (mean age 67 years) who lived in three Greek towns with different levels of Mn in their drinking water (4.0–15.0, 80–250, and 1800–2300 µg/L). As the Mn concentration in drinking water increased, the average neurological score increased (2.7, 3.9, and 5.2, respectively). The authors<sup><xref ref-type="bibr" rid="bibr78-0960327112456316">78</xref></sup> concluded that increased Mn in drinking water was associated with increased hair Mn levels and they were concerned with the significant association between use of groundwater containing 0.082–0.25 mg Mn/L and an increase in the prevalence of neurologic signs consistent with extrapyramidal dysfunction. The ATSDR<sup><xref ref-type="bibr" rid="bibr36-0960327112456316">36</xref></sup> interpreted those results as suggestive that chronic consumption of drinking water with relatively high Mn concentrations ‘might contribute to an increased prevalence of neurological effects in the aged’, but qualified that conclusion with the caveat that Kondakis et al.<sup><xref ref-type="bibr" rid="bibr78-0960327112456316">78</xref></sup> failed to verify that those who complained of neurologic symptoms actually ingested higher Mn levels than those who did not register such complaints.</p>
<p>Vieregge et al.<sup><xref ref-type="bibr" rid="bibr79-0960327112456316">79</xref></sup> found a somewhat (but not significantly) higher blood Mn (8.5 ± 2.3 µg/L) in 41 people living in Northern Germany (mean age = 57.5 years) who consumed well water containing 300–2160 μg Mn/L for at least 10 years (and up to 40 years) compared with that in a referent group of 74 people (mean age = 56.9 years) who used water containing 7.7 ± 2.0 µg Mn/L. However, there was no increase in the prevalence of signs of manganism, and similar to the report of Kondakis et al.,<sup><xref ref-type="bibr" rid="bibr78-0960327112456316">78</xref></sup> the authors<sup><xref ref-type="bibr" rid="bibr79-0960327112456316">79</xref></sup> failed to take into account dietary Mn contribution to total daily dose. Iwami et al.<sup><xref ref-type="bibr" rid="bibr80-0960327112456316">80</xref></sup> correlated the incidence of motor neuron disease in a small Japanese town with elevated Mn in local rice. In this case, the concentrations of Mn in drinking water were low, but failure to document daily Mn exposure in light of other nutritional deficiencies compromised interpretation of those observations.</p>
<p>Bouchard and associates<sup><xref ref-type="bibr" rid="bibr81-0960327112456316">81</xref></sup> measured hair Mn concentrations in 24 boys and 22 girls (6–15 years old) who lived in homes supplied with well water containing total Mn at a mean concentration 500 ± 129 µg/L with a maximum of 610 µg/L. Those who used water with higher Mn (<italic>N</italic> = 28) had significantly higher Mn concentrations in/on their hair and had higher scores for hyperactivity and oppositional behavior than those who used well water with the lower Mn concentration (<italic>N</italic> = 18). One problem here (other than the very small sample size and self-selection of the study participants) was the fact that most of the parents admitted they purchased bottled water because of the bad taste of the well water; only 9% of the households actually drank the water, yet 96% said they used it for cooking. Bouchard et al.<sup><xref ref-type="bibr" rid="bibr81-0960327112456316">81</xref></sup> highlighted a second problem in that the laboratory protocol did not include washing the hair prior to Mn analytical measurement and, third, that hair color, age of the person, and hair dyes all influence hair Mn content.</p>
<p>Bouchard et al.<sup><xref ref-type="bibr" rid="bibr82-0960327112456316">82</xref></sup> published the results of follow-up cross-sectional study of 362 children (ages 6–13 years) from 251 families who lived in homes with well water (47%) or in homes with municipal water (53%) and who had lived in the same house for at least 3 months. Tap water Mn concentrations ranged from 1.0 to 2700 µg/L (arithmetic mean = 95 µg/L with an upper 95% concentration of 255 µg/L). Drinking water Mn was lower in homes with private wells (geometric mean = 8 µg/L) compared with those with drinking water supplied by public wells (55 µg/L). Mn intake from drinking water (including domestic water used in food preparation) ranged from 0 to 286 µg/kg/month with the highest recorded at 945 µg/kg/month. Bouchard et al.<sup><xref ref-type="bibr" rid="bibr82-0960327112456316">82</xref></sup> made no mention of clinical abnormalities among any of the 362 participants, but reported that reduced performance on IQ tests was correlated with tap water Mn (but not with dietary Mn). Chen and Cope<sup><xref ref-type="bibr" rid="bibr83-0960327112456316">83</xref></sup> questioned those conclusions since the participants’ dietary Mn consumption (2355 µg/kg-month) was far higher than that from water and 121 of the participants (33%) admitted they did not drink tap water at home.</p>
<p>This same group<sup><xref ref-type="bibr" rid="bibr84-0960327112456316">84</xref></sup>
<sup>–</sup>
<sup><xref ref-type="bibr" rid="bibr86-0960327112456316">86</xref></sup> conducted clinical evaluations, behavioral assessments, and evaluated children’s performance on academic achievement tests in relation to home tap water Mn concentrations. Clinical evaluation (body weight, head circumference, and blood and urine Mn concentrations) and classroom behavior (focusing on the disruptive) of 210 children who had home drinking water with Mn at 40–3442 µg/L made no mention of any sign of local or systemic Mn intoxication, but there was a weak (<italic>p</italic> = 0.056) association between drinking water Mn and blood Mn.<sup><xref ref-type="bibr" rid="bibr84-0960327112456316">84</xref></sup> Cross-sectional assessment of 840 children (ages 8–11 years) using academic test results found a 6% decrement in scores on mathematics among those whose domestic tap water contained &gt;400 µg Mn/L; again there was no suggestion of local or systemic Mn intoxication.<sup><xref ref-type="bibr" rid="bibr85-0960327112456316">85</xref></sup> Nonetheless, Khan et al.<sup><xref ref-type="bibr" rid="bibr84-0960327112456316">84</xref></sup>
<sup>,</sup>
<sup><xref ref-type="bibr" rid="bibr85-0960327112456316">85</xref></sup> gave no indication that these children actually drank home tap water with &gt;400 µg Mn/L. Parvez et al.<sup><xref ref-type="bibr" rid="bibr86-0960327112456316">86</xref></sup> then studied four groups of 75 children each (ages 8–11 years), who used household well water containing 184 ± 146, 202 ± 145, 1111 ± 686, or 1367 ± 692 µg Mn/L. The chemical form/forms of Mn in tap water was/were not identified, but the water contained elevated arsenic (43 ± 74 µg/L). No mention of clinical signs consistent with acute or chronic Mn intoxication was made, but there was no significant difference in circulating Mn among children using water with elevated Mn compared with those using water with lower Mn levels. There were no differences in gender, mother’s age, number of siblings, duration of well water use, demographic or anthropometric parameters or performance on fine manual motor skill, manual coordination, body coordination, and results of tests for strength and agility that could be attributed to drinking water Mn exposure. It was not clear from the report that what proportion of children living in homes with elevated Mn in tap water actually drank the water.</p>
<p>The ATSDR<sup><xref ref-type="bibr" rid="bibr36-0960327112456316">36</xref></sup> summarized two case reports<sup><xref ref-type="bibr" rid="bibr16-0960327112456316">16</xref></sup>
<sup>,</sup>
<sup><xref ref-type="bibr" rid="bibr87-0960327112456316">87</xref></sup> and three cross-sectional or comparative studies<sup><xref ref-type="bibr" rid="bibr88-0960327112456316">88</xref></sup>
<sup>–</sup>
<sup><xref ref-type="bibr" rid="bibr90-0960327112456316">90</xref></sup> that evaluated potential neurologic disease, impaired learning and reduced intellectual performance as a result of consuming drinking water with elevated Mn. The 6-year-old described by Sahni et al.<sup><xref ref-type="bibr" rid="bibr87-0960327112456316">87</xref></sup> used well water containing 2200 µg Mn/L and she experienced progressive neurologic symptoms and became unable to stand alone; following chelation therapy, she recovered. The report by Woolf and coauthors<sup><xref ref-type="bibr" rid="bibr16-0960327112456316">16</xref></sup> is of interest since the family used well water containing 1.2 mg Mn/L. The authors noted that the water was turbid and had a metallic taste; test results for learning, IQ, and cognition on a 10-year-old boy were normal, but his elevated serum Mn (0.90 μg/dL compared with the normal level of &lt;0.26 μg/dL) and suggestive findings of impaired short-term verbal and visual memory lead the authors<sup><xref ref-type="bibr" rid="bibr16-0960327112456316">16</xref></sup> to suggest that children may be more sensitive to excess Mn than adults. The He et al.<sup><xref ref-type="bibr" rid="bibr88-0960327112456316">88</xref></sup> and Zhang et al.<sup><xref ref-type="bibr" rid="bibr90-0960327112456316">90</xref></sup> reports concern the same group of Chinese children who were exposed to elevated Mn associated with sewage irrigation. He et al.<sup><xref ref-type="bibr" rid="bibr88-0960327112456316">88</xref></sup> examined 92 children (ages 11–13 years) who consumed well water containing 240–350 µg Mn/L and concluded there were increased problems with short-term memory and manual dexterity compared with children who drank water containing 40 µg Mn/L. The study by Wasserman et al.<sup><xref ref-type="bibr" rid="bibr89-0960327112456316">89</xref></sup> involved 142 children (ages 9.5–10.5 years) who used water from wells containing 103, 440, 801, 1923 and up to 3908 µg Mn/L (mean = 793 μg Mn/L); after adjusting sociodemographic factors, performance on the Wechsler Intelligence Scale for Children was inversely related to the Mn concentration in drinking water. Wasserman et al.<sup><xref ref-type="bibr" rid="bibr89-0960327112456316">89</xref></sup> made no attempt to estimate dietary Mn intake for any of the study participants and there was no relationship between blood Mn and intellectual performance. Despite medical observation during venipuncture, there was no mention of any adverse clinical sign of acute or chronic manganism made in the report.</p>
<p>ATSDR<sup><xref ref-type="bibr" rid="bibr36-0960327112456316">36</xref></sup> considered all these reports of limited value due to problems with selection of the referent groups, test administration, exposure assessment (including dietary Mn contribution), and confounding factors (including the presence of other metals in the water). Some authors have suggested that Mn levels are elevated in people with learning disabilities, amyotrophic lateral sclerosis or who exhibit violent behavior, but none of those suggestions have been verified.<sup><xref ref-type="bibr" rid="bibr36-0960327112456316">36</xref></sup> In contrast to the reports of Mn exposure via drinking water, controlled trials with dietary Mn are robust; for example, when healthy young women consumed supplemental dietary Mn at 0.8 or 20 mg Mn/day for 8 weeks, there were no adverse effects on biliary function, activities of plasma glutathione peroxidase, catalase or superoxide dismutase, glucose, insulin, hemoglobin capacity or total whole blood iron-binding capacity, neurologic parameters or psychological measures of hostility, anger, negativism, positive attitude, and self-assurance.<sup><xref ref-type="bibr" rid="bibr75-0960327112456316">75</xref></sup>
</p>
</sec>
<sec id="section8-0960327112456316">
<title>Inhalation, dermal and other routes of exposure</title>
<p>Although inhaled dusts of MnO<sub>2</sub> or Mn<sub>3</sub>O<sub>4</sub> can produce pneumonitis, most of the concern regarding environmental Mn exposure is related to the symptoms of chronic manganism seen miners, welders, and those employed in battery and ferroalloy plants where inhaled dusts containing &gt;0.2–1 mg Mn/m<sup>3</sup> or fume that can result in progressive emotional, memory, and clinical motor disturbances. Somewhat lower exposures can alter visual reaction times, eye-hand coordination, hand steadiness, and libido and repeated Mn dust or fume exposure can increase fatigue and irritability.<sup><xref ref-type="bibr" rid="bibr36-0960327112456316">36</xref></sup>
<sup>,</sup>
<sup><xref ref-type="bibr" rid="bibr91-0960327112456316">91</xref></sup>
<sup>,</sup>
<sup><xref ref-type="bibr" rid="bibr92-0960327112456316">92</xref></sup>
</p>
<p>While there are descriptions of dermal exposure to Mn compounds in humans,<sup><xref ref-type="bibr" rid="bibr92-0960327112456316">92</xref></sup>
<sup>,</sup>
<sup><xref ref-type="bibr" rid="bibr93-0960327112456316">93</xref></sup> uptake of ionized Mn across intact skin is expected to be limited. Elevated urinary Mn levels were observed in a man burned with a hot acid solution containing 6% Mn.<sup><xref ref-type="bibr" rid="bibr94-0960327112456316">94</xref></sup> Ten children with atopic dermatitis aged 5 months to 9 years (mean age 35.5 months) received topical KMnO<sub>4</sub> at 1:20,000 (80,000 µg/L) once daily for 7 days along with a topical corticosteroid.<sup><xref ref-type="bibr" rid="bibr33-0960327112456316">33</xref></sup> Local skin irritation was noted in two of the 10 patients after 7 days of treatment, but no further details were reported. Although other concentrations (1:1,000; 1:10,000; and 1:50,000) were evaluated for bacteriocidal activity after 5 min of skin contact, irritation was not assessed for those concentrations.</p>
<p>Intentional intravaginal administration of aqueous KMnO<sub>4</sub> solutions or tablets in criminal or self-inflicted efforts to induce abortion is notuncommon.<sup><xref ref-type="bibr" rid="bibr95-0960327112456316">95</xref></sup>
<sup>–</sup>
<sup><xref ref-type="bibr" rid="bibr112-0960327112456316">112</xref></sup> In some cases, the mother died.<sup><xref ref-type="bibr" rid="bibr112-0960327112456316">112</xref></sup> In a review of 23 British cases, Obeng<sup><xref ref-type="bibr" rid="bibr107-0960327112456316">107</xref></sup> noted that all of the women suffered caustic burns of the vaginal fornix, but none terminated their pregnancy and the vast majority delivered healthy offspring.</p>
<p>Direct ocular contact with crystals or concentrated KMnO<sub>4</sub> solutions will burn and stain the affected area purple to brown-black,<sup><xref ref-type="bibr" rid="bibr113-0960327112456316">113</xref></sup> and these materials can burn the eye<sup><xref ref-type="bibr" rid="bibr114-0960327112456316">114</xref></sup> and mucous membranes leading to perforations.<sup><xref ref-type="bibr" rid="bibr95-0960327112456316">95</xref></sup>
<sup>–</sup>
<sup><xref ref-type="bibr" rid="bibr97-0960327112456316">97</xref></sup> Decreased visual acuity, corneal clouding, subconjunctival hemorrhages, and brownish conjunctival discoloration were described in a 22-year-old male subject who sustained burns to his eyes as a result of ocular contact with KMnO<sub>4</sub> crystals.<sup><xref ref-type="bibr" rid="bibr114-0960327112456316">114</xref></sup> There is one account by Sigg et al.<sup><xref ref-type="bibr" rid="bibr115-0960327112456316">115</xref></sup> wherein a man splashed a concentrated (but unspecified) solution of KMnO<sub>4</sub> into both eyes. He complained of a foreign-body type irritation and developed several hard eroded lesions that appeared as granular deposits on his conjunctiva.</p>
</sec>
</sec>
<sec id="section9-0960327112456316">
<title>Effects on laboratory animals</title>
<p>The literature concerning Mn toxicity in rodents is extensive and most of the studies are concerned with its neurotoxic mode of action or chronic exposure to inhaled MnSO<sub>4</sub>, MnO<sub>2</sub> or the gasoline additive methylcyclopentadienyl manganese tricarbonyl. There are limited published reports concerning KMnO<sub>4</sub> per se.</p>
<p>A number of studies considered ingested MnCl<sub>2</sub> or mixed MnCl<sub>2</sub>/MnO in mice and rats, but many of those protocols examined only a single level of Mn exposure (reviewed by Gwiazda et al.<sup>
<xref ref-type="bibr" rid="bibr92-0960327112456316">92</xref>
</sup> and US EPA<sup>
<xref ref-type="bibr" rid="bibr116-0960327112456316">116</xref>
</sup>). Studies in rodents report variable changes in neurotransmitters including increased striatal γ-aminobutyric acid, but repeated Mn injections (7–59 weeks) in nonhuman primates at 3–10 mg Mn/kg/week found normal markers of glutamatergic and GABAeric neurotransmission.<sup>
<xref ref-type="bibr" rid="bibr117-0960327112456316">117</xref>
</sup> Very high cumulative parenteral doses (&gt;260 mg Mn/kg) given to monkeys induce motor deficits and pathology (gliosis) in the frontal cortex, globus pallidus, caudate, and striatum.<sup>
<xref ref-type="bibr" rid="bibr92-0960327112456316">92</xref>,<xref ref-type="bibr" rid="bibr117-0960327112456316">117</xref>
</sup>
</p>
<p>With respect to neurological impairment, not only do the rodents not display the signs of extrapyramidal deficits characteristic of clinical manganism but also the species difference in dietary requirements are such that humans require only 1/100th of the daily dietary Mn on a body weight basis compared with rodents.<sup>
<xref ref-type="bibr" rid="bibr77-0960327112456316">77</xref>,<xref ref-type="bibr" rid="bibr116-0960327112456316">116</xref>
</sup> Furthermore, internal cumulative doses required to elicit Mn-induced toxicity in rodents are at least 100 × greater than those after which humans show impaired neurologic function.<sup>
<xref ref-type="bibr" rid="bibr92-0960327112456316">92</xref>
</sup>
</p></sec>
<sec id="section10-0960327112456316">
<title>Acute exposure</title>
<sec id="section11-0960327112456316">
<title>Oral</title>
<p>Acute oral median lethal dose (LD<sub>50</sub>) values for KMnO<sub>4</sub> have been reported in rats (1090 mg/kg)<sup><xref ref-type="bibr" rid="bibr118-0960327112456316">118</xref></sup> and mice (1449 mg/kg).<sup><xref ref-type="bibr" rid="bibr119-0960327112456316">119</xref></sup> Single lethal dose values range from 400mg/kg in dogs, 600 mg/kg in rabbits, 750–2157 mg/kg in mice to 810–1151 mg/kg in guinea pigs.<sup><xref ref-type="bibr" rid="bibr120-0960327112456316">120</xref></sup> The acute oral LD<sub>50</sub> in male Swiss mice for KMnO<sub>4</sub> referenced by Joardar and Sharma<sup><xref ref-type="bibr" rid="bibr121-0960327112456316">121</xref></sup> was 1600 mg/kg, a value somewhat greater than the single dose oral LD<sub>50</sub> values of MnCl<sub>2</sub>, MnSO<sub>4</sub>, and Mn<sub>3</sub>O<sub>4</sub> in rats and mice that range from 225 to 1082 mg/kg.<sup><xref ref-type="bibr" rid="bibr118-0960327112456316">118</xref></sup>
<sup>,</sup>
<sup><xref ref-type="bibr" rid="bibr121-0960327112456316">121</xref></sup>
<sup>–</sup>
<sup><xref ref-type="bibr" rid="bibr125-0960327112456316">125</xref></sup> Kostial et al.<sup><xref ref-type="bibr" rid="bibr123-0960327112456316">123</xref></sup> observed that acute LD<sub>50</sub> values of MnCl<sub>2</sub> in fed albino rats varied with age and that the lowest single dose oral LD<sub>50</sub> (619 mg/kg) was seen in older animals.</p>
<p>After Kojima et al.<sup><xref ref-type="bibr" rid="bibr126-0960327112456316">126</xref></sup> gave a single oral gavage of 100, 200, or 400 mg/kg MnCl<sub>2</sub> to fasted male Wistar rats, circulating and peripheral tissue Mn concentrations increased, but none of the animals died; furthermore, there was no effect on body weight. No rats died after daily oral MnCl<sub>2</sub> intubations at 100 mg Mn were carried out over 90 days. Lipe et al.<sup><xref ref-type="bibr" rid="bibr127-0960327112456316">127</xref></sup> stated that a single intraperitoneal injection of 10 mg/kg MnCl<sub>2</sub> killed adult rats ‘within days’, but the single bolus oral and parenteral mortality results stand in contrast to repeated dietary administration where feeding 1300–2251 mg Mn/kg/day (as MnSO<sub>4</sub> or MnCl<sub>2</sub>) to rats and mice failed to influence survival.<sup><xref ref-type="bibr" rid="bibr128-0960327112456316">128</xref></sup>
<sup>,</sup>
<sup><xref ref-type="bibr" rid="bibr129-0960327112456316">129</xref></sup>
</p>
</sec>
<sec id="section12-0960327112456316">
<title>Dermal or ocular</title>
<p>Little information is available on the irritant and contact sensitivity properties of Mn compounds,<sup><xref ref-type="bibr" rid="bibr120-0960327112456316">120</xref></sup> but Mn salts were negative in the murine local lymph node assay.<sup><xref ref-type="bibr" rid="bibr130-0960327112456316">130</xref></sup> No quantitative studies with direct instillation of KMnO<sub>4</sub> into the eye or application onto the intact skin of laboratory animals were located.</p>
</sec>
</sec>
<sec id="section13-0960327112456316">
<title>Repeat dose studies</title>
<p>No repeated dose studies with KMnO<sub>4</sub> by any route in any species of laboratory animals were located other than one non-English report that identified behavioral changes in rats after (unspecified oral) the treatment with 7851 mg/kg,<sup>
<xref ref-type="bibr" rid="bibr120-0960327112456316">120</xref>
</sup> and another report<sup>
<xref ref-type="bibr" rid="bibr121-0960327112456316">121</xref>
</sup> that identified a dose-dependent increase in chromosome aberrations in the bone marrow of male Swiss mice were given an oral dose of KMnO<sub>4</sub> at 65, 130, or 380 mg/kg for over 21 days. However, as the Russian oral dose was substantially greater than the rat oral LD<sub>50</sub>,<sup>
<xref ref-type="bibr" rid="bibr118-0960327112456316">118</xref>
</sup> the validity of that report may be problematic. The oral (details of administration not provided) study of KMnO<sub>4</sub> and bone marrow clastogenicity in mice<sup>
<xref ref-type="bibr" rid="bibr121-0960327112456316">121</xref>
</sup> reported increased aberrations at the two lower doses, but not at the highest dose (representing 20% of a lethal dose). No information concerning clinical signs, food or drinking water consumption, body weight, gross necropsy, or histopathology was given. The numbers of scored chromosomal aberrations per cell were much higher than normally reported and it is possible that chromosome and chromatid gaps were counted as breaks.<sup>
<xref ref-type="bibr" rid="bibr121-0960327112456316">121</xref>
</sup>
</p>
<p>While repeated oral dose studies with various Mn salts have been published (<xref ref-type="table" rid="table3-0960327112456316">Table 3</xref>),<sup>
<xref ref-type="bibr" rid="bibr127-0960327112456316">127</xref>,<xref ref-type="bibr" rid="bibr131-0960327112456316">131</xref>
<xref ref-type="bibr" rid="bibr132-0960327112456316"/>
<xref ref-type="bibr" rid="bibr133-0960327112456316"/>
<xref ref-type="bibr" rid="bibr134-0960327112456316"/>
<xref ref-type="bibr" rid="bibr135-0960327112456316"/>
<xref ref-type="bibr" rid="bibr136-0960327112456316"/>
<xref ref-type="bibr" rid="bibr137-0960327112456316"/>
<xref ref-type="bibr" rid="bibr138-0960327112456316"/>
<xref ref-type="bibr" rid="bibr139-0960327112456316"/>
<xref ref-type="bibr" rid="bibr140-0960327112456316"/>
<xref ref-type="bibr" rid="bibr141-0960327112456316"/>
<xref ref-type="bibr" rid="bibr142-0960327112456316"/>
<xref ref-type="bibr" rid="bibr143-0960327112456316"/>–<xref ref-type="bibr" rid="bibr144-0960327112456316">144</xref>
</sup> the relevance of changes in neurotransmitter levels in rodents after Mn exposure to humans has been called into question.<sup>
<xref ref-type="bibr" rid="bibr72-0960327112456316">72</xref>,<xref ref-type="bibr" rid="bibr145-0960327112456316">145</xref>
</sup>
</p>
<table-wrap id="table3-0960327112456316" position="float">
<label>Table 3.</label>
<caption>
<p>Repeat dose manganese oral toxicity studies in rodents.</p>
</caption>
<graphic alternate-form-of="table3-0960327112456316" xlink:href="10.1177_0960327112456316-table3.tif"/>
<table>
<thead>
<tr>
<th>Compound</th>
<th>Strain/species/sex</th>
<th>Exposure/route/frequency/duration</th>
<th>Concentration/dose</th>
<th>Response</th>
<th>Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td>MnCl<sub>2</sub>
</td>
<td>Sprague-Dawley rat, ♀</td>
<td>Gavage, 30 days</td>
<td>0, 10, or 20 mg Mn/kg-day</td>
<td>Reduced body weight gain in adult, but not in weanling rats; ↑ Cerebellar aspartate, glutamate, GABA at 20 mg/kg-day </td>
<td>Lipe et al.<sup>
<xref ref-type="bibr" rid="bibr127-0960327112456316">127</xref>
</sup>
</td>
</tr>
<tr>
<td>MnCl<sub>2</sub> <bold>·</bold> 4H<sub>2</sub>O</td>
<td>ITRC albino rat</td>
<td>Drinking water, 30 days</td>
<td>0 or 1000 mg/L</td>
<td>No change in body weight or behavior; ↑ Corpus striatum Mn</td>
<td>Shukla and Chandra<sup>
<xref ref-type="bibr" rid="bibr131-0960327112456316">131</xref>
</sup>
</td>
</tr>
<tr>
<td>Mn (not specified)</td>
<td>ITRC albino rat, ♀</td>
<td>Drinking water, 30 days</td>
<td>0 or 1 mg/mL</td>
<td>↑ Fighting; ↑ Striatal Mn; ↑ Striatal DA and NE</td>
<td>Chandra<sup>
<xref ref-type="bibr" rid="bibr132-0960327112456316">132</xref>
</sup>
</td>
</tr>
<tr>
<td>MnCl<sub>2</sub>
</td>
<td>Wistar rat, ♀</td>
<td>Drinking water, 30 days</td>
<td>0 or 1000 mg/L</td>
<td>No difference in food or water consumption, mortality, or behavior; ↑ Cortex, striatum, and hypothalamus Mn</td>
<td>Subhash and Padmashree<sup>
<xref ref-type="bibr" rid="bibr133-0960327112456316">133</xref>
</sup>
</td>
</tr>
<tr>
<td>MnCl<sub>2</sub> <bold>·</bold> 4H<sub>2</sub>O</td>
<td>Wistar rat, ♀; Bile-duct ligated, sham or control</td>
<td>Drinking water, 4 weeks</td>
<td>0, 0.5, or 1.0 mg Mn/L</td>
<td>Dose-dependent 57% ↑ striatal Mn with liver damage; ↑ striatal dopamine and HVA with liver damage</td>
<td>Montes et al.<sup>
<xref ref-type="bibr" rid="bibr134-0960327112456316">134</xref>
</sup>
</td>
</tr>
<tr>
<td>MnCl<sub>2</sub>
</td>
<td>Wistar rat, ♂</td>
<td>Drinking water, 60 days</td>
<td>0, 1000, 10,000, or 20,000 mg/L (0.39, 390, and 778  mg Mn/kg-day)</td>
<td>↑ Hepatic necrosis at &gt;39 mg/kg-day </td>
<td>Leung et al.<sup>
<xref ref-type="bibr" rid="bibr135-0960327112456316">135</xref>
</sup>
</td>
</tr>
<tr>
<td>MnCl<sub>2</sub>
</td>
<td>Sprague-Dawley rat, ♀</td>
<td>Drinking water, 60 days</td>
<td>0 or 10 mg Mn/mL</td>
<td>↑ Caudate nucleus Mn and GABA</td>
<td>Bonilla<sup>
<xref ref-type="bibr" rid="bibr136-0960327112456316">136</xref>
</sup>
</td>
</tr>
<tr>
<td>MnCl<sub>2</sub>
</td>
<td>Wistar rat, ♀</td>
<td>Drinking water, 10 weeks</td>
<td>0 or 20 mg/mL</td>
<td>↑ Basal ganglia, cortex, cerebellum, and liver Mn; ↑ Physical activity; No change in forebrain or midbrain histology</td>
<td>Calabresi et al.<sup>
<xref ref-type="bibr" rid="bibr137-0960327112456316">137</xref>
</sup>
</td>
</tr>
<tr>
<td>Mn<sup>+2</sup> (form not specified)</td>
<td>Wistar rat, ♀</td>
<td>Drinking water, 13 weeks</td>
<td>0 or 20,000 mg/L</td>
<td>↑ Brain Mn; No histologic change in globus pallidus; no change in open-field or radial maze performance</td>
<td>Spadoni et al.<sup>
<xref ref-type="bibr" rid="bibr138-0960327112456316">138</xref>
</sup>
</td>
</tr>
<tr>
<td>MnCl<sub>2</sub>
</td>
<td>Sprague-Dawley rat, ♀</td>
<td>Drinking water, 32 weeks</td>
<td>0, 0.1, or 5.0 mg Mn/mL</td>
<td>Variable nondose related changes in physical activity</td>
<td>Bonilla<sup>
<xref ref-type="bibr" rid="bibr139-0960327112456316">139</xref>
</sup>
</td>
</tr>
<tr>
<td>MnCl<sub>2</sub>
</td>
<td>Sprague-Dawley rat ♀</td>
<td>Drinking water, 32 weeks</td>
<td>0, 0.1, or 1.0 mg Mn/mL</td>
<td>↓ Pons, striatum norepinephrine; ↓ Hypothalamus, striatum DOPAC</td>
<td>Bonilla and Prasad<sup>
<xref ref-type="bibr" rid="bibr140-0960327112456316">140</xref>
</sup>
</td>
</tr>
<tr>
<td>MnCl<sub>2</sub>
</td>
<td>Charles River rat ♀ </td>
<td>Drinking water, 24 weeks</td>
<td>0, 50, 200, 700, or 2000 mg/L</td>
<td>↑ Striatial dopamine 2000 mg/L; ↓ Corpus striatal Mn at 200 mg/L, but no dose-response</td>
<td>Bull<sup>
<xref ref-type="bibr" rid="bibr141-0960327112456316">141</xref>
</sup>
</td>
</tr>
<tr>
<td>MnCl<sub>2</sub> <bold>·</bold> 4H<sub>2</sub>O</td>
<td>Sprague-Dawley rat, ♀</td>
<td>Drinking water, 65 weeks</td>
<td>0 or 1000 mg/L (as hydrate)</td>
<td>Transient ↑ locomotor activity; no change body weight gain</td>
<td>Nachtman et al.<sup>
<xref ref-type="bibr" rid="bibr142-0960327112456316">142</xref>
</sup>
</td>
</tr>
<tr>
<td>MnCl<sub>2</sub> <bold>·</bold> 4H<sub>2</sub>O</td>
<td>Sprague-Dawley rat, ♀</td>
<td>Drinking water, 60, 100, 165, or 265 days</td>
<td>0 or 10 g/L</td>
<td>↑ DA and DOPAC at 60 and 165 days, but no change at 100 or 265 days</td>
<td>Eriksson et al.<sup>
<xref ref-type="bibr" rid="bibr143-0960327112456316">143</xref>
</sup>
</td>
</tr>
<tr>
<td>MnCl<sub>2</sub>; Mn(CH<sub>3</sub>COO)<sub>2</sub>; MnCO<sub>3</sub>; MnO<sub>2</sub>
</td>
<td>ddY mouse ♀</td>
<td>Dietary, 12 months</td>
<td>130 mg Mn/kg or 2000 mg Mn/kg</td>
<td>No change in food consumption; ↓ Body weight gain; ↑ Brain Mn; ↓ Hypothalamus DA; ↓ Locomotor activity MnO<sub>2</sub>
</td>
<td>Komura and Sakamoto<sup>
<xref ref-type="bibr" rid="bibr144-0960327112456316">144</xref>
</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-0960327112456316">
<p>GABA: γ-aminobutyric acid; DA: dopamine; NE: norepinephrine; ♀: male; ♂: female; ↑: increase; ↓: decrease; HVA: homovanillic acid (a primary dopamine metabolite); DOPAC: 3,4-dihydroxyphenylacetic acid.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>More than toxicity, it is Mn deficiency that is generally of greater concern.<sup>
<xref ref-type="bibr" rid="bibr145-0960327112456316">145</xref>
</sup> A case in point is the fact that the offspring of pregnant rodents maintained on Mn-deficient diets were afflicted with axial skeletal malformations<sup>
<xref ref-type="bibr" rid="bibr146-0960327112456316">146</xref>
</sup> and survivors developed ataxia.<sup>
<xref ref-type="bibr" rid="bibr147-0960327112456316">147</xref>
</sup> The incoordination and loss of equilibrium induced by prenatal Mn deficiency cannot be mitigated with supplemental dietary Mn after birth as these signs result from malformations of the otoliths of the utricular and saccular maculae.<sup>
<xref ref-type="bibr" rid="bibr148-0960327112456316">148</xref>
</sup> Defects of the vestibular portion of the inner ear arise from the same reductions in mucopolysaccharide production that are responsible for the deficiency-induced epiphyseal dysplasia and skeletal reductions.<sup>
<xref ref-type="bibr" rid="bibr149-0960327112456316">149</xref>
</sup> Mn deficiency is teratogenic in rodents, but there are no reports of human congenital malformation attributed to low Mn status.<sup>
<xref ref-type="bibr" rid="bibr150-0960327112456316">150</xref>
</sup>
</p>
<p>Ingestion of up to 1300 mg/kg/day as MnSO<sub>4</sub> by F344 rats for 14 days reduced body weight gains, but feeding MnSO<sub>4</sub> failed to influence their survival.<sup>
<xref ref-type="bibr" rid="bibr128-0960327112456316">128</xref>
</sup> Studies with B6C3F1 mice found that feeding MnSO<sub>4</sub> for 14 days failed to influence either body weight gain or survival.<sup>
<xref ref-type="bibr" rid="bibr128-0960327112456316">128</xref>
</sup> Ingestion of up to 2251 mg/kg/day as MnCl<sub>2</sub> for up to 6 months by male mice also failed to alter survival.<sup>
<xref ref-type="bibr" rid="bibr129-0960327112456316">129</xref>
</sup>
</p>
<p>Dorman and coworkers<sup>
<xref ref-type="bibr" rid="bibr151-0960327112456316">151</xref>
</sup> gave oral doses of MnCl<sub>2</sub> to CD rats at 0, 25, or 50 mg/kg/day from birth to day 21. In a companion study, adult male CD rats were given identical doses over the same duration. Neonates that received the highest dose displayed reduced body weight gain, increase startle response and increased hypothalamic, striatal, hippocampal, hindbrain, and cerebellar Mn concentrations. Although there were no treatment-related changes in clinical signs, motor activity, passive avoidance, or neuropathology, neonates given the highest dose had increased striatal dopamine and 3, 4-dihydroxyphenylacetic acid. Adult rats given the highest dose accumulated Mn in the brain. Dorman et al.<sup>
<xref ref-type="bibr" rid="bibr151-0960327112456316">151</xref>
</sup> suggested that newborn rats were more susceptible to that adverse effects of ingested Mn compared with adult rats fed with the same levels of MnCl<sub>2</sub>.</p>
</sec>
<sec id="section14-0960327112456316">
<title>Long-term studies</title>
<p>No controlled chronic studies with KMnO<sub>4</sub> in laboratory animals by any route were located. There are suggestions that Mn-deficient rodents tend to accumulate a higher Mn body burden and that feeding high dietary Mn<sub>3</sub>O<sub>4</sub> levels over a prolonged period can reduce tissue iron (Fe) stores.<sup>
<xref ref-type="bibr" rid="bibr152-0960327112456316">152</xref>
</sup> Feeding Mn (400–1100 ppm) to Long Evans rats in an Fe-deficient diet for 100–224 days induced microcytic anemia.<sup>
<xref ref-type="bibr" rid="bibr153-0960327112456316">153</xref>
</sup>
</p>
<p>The NRC<sup>
<xref ref-type="bibr" rid="bibr38-0960327112456316">38</xref>
</sup> summarized the older literature concerning long-term Mn intoxication and neurobehavioral alterations in nonhuman primates. Most primate studies used parenteral injections (intravenous, subcutaneous, and intramuscular) and examined MnSO<sub>4</sub>,<sup>
<xref ref-type="bibr" rid="bibr154-0960327112456316">154</xref>
</sup> MnCl<sub>2</sub>, or MnO<sub>2</sub>, whereas other studies involved airborne MnSO<sub>4</sub> or the phosphate or aerosols of manganese oxides (reviewed in ATSDR<sup>
<xref ref-type="bibr" rid="bibr36-0960327112456316">36</xref>
</sup>). Neurobehavioral evaluations of rats and mice failed to encompass the wide range of changes seen in manganism and ATSDR<sup>
<xref ref-type="bibr" rid="bibr38-0960327112456316">38</xref>
</sup> considered the parenteral data of limited utility.</p>
<p>In the evaluation of Mn nutritional supplements, Golub et al.<sup>
<xref ref-type="bibr" rid="bibr155-0960327112456316">155</xref>
</sup> gave groups of eight male infant Rhesus monkeys either a soy formula with 1.0 mg Mn/L (as MnCl<sub>2</sub>) or the soy formula with 0.30 mg Mn/L or a cow’s milk formula with 0.05 mg Mn/L to 4 months of age. The group given the highest total Mn dose (107.5 Mn/kg/day) was said to be ‘more active’ than those given the soy or cow’s milk alone.</p>
<p>In the only oral Mn toxicity (as contrast to nutritional) study conducted in nonhuman primates, Gupta et al.<sup>
<xref ref-type="bibr" rid="bibr156-0960327112456316">156</xref>
</sup> gave 6.9 mg Mn/kg/day as MnCl<sub>2</sub> to four male rhesus monkeys for 18 months. The monkeys developed weakness in skeletal muscles with rigidity of their lower limbs; necropsy identified depigmentation and neuronal degeneration within the substantia nigra. The WHO<sup>
<xref ref-type="bibr" rid="bibr157-0960327112456316">157</xref>
</sup> considered the Gupta et al.<sup>
<xref ref-type="bibr" rid="bibr156-0960327112456316">156</xref>
</sup> results to be of limited utility primarily because only one dose level was evaluated.</p>
</sec>
<sec id="section15-0960327112456316">
<title>Absorption, distribution and elimination</title>
<p>After reviewing more than 100 publications, Gwiazda and associates<sup>
<xref ref-type="bibr" rid="bibr92-0960327112456316">92</xref>
</sup> concluded that while systemic bioavailability of inhaled Mn was essentially equivalent to that after intravenous injection (100%), systemic uptake of ingested inorganic Mn (e.g. chloride and oxide) was not more than 3% (0.03). It is this marked difference in bioavailability as a function of different routes of exposure and the properties of different Mn chemical forms that account in large measure for the differences in dose required to elicit adverse effects. However, ingestion of the water soluble salts (e.g. MnCl<sub>2</sub>) can induce systemic toxicity at lower doses than ingestion of insoluble forms (e.g. MnO<sub>2</sub>).</p>
<p>In controlled studies with dietary Mn, women received a somewhat smaller daily Mn dose (3.2–4.6 mg/day) compared with men (3.9–6.3 mg/day) given the same foods, but women absorbed a greater percentage of ingested Mn (3.5%) compared with the men. Of note were the observations that there were no significant gender-related differences in plasma Mn and that women had a more rapid rate of whole body Mn elimination than men; this difference was reflected in the shorter mean half-time (34 days) compared with men (48 days).<sup>
<xref ref-type="bibr" rid="bibr74-0960327112456316">74</xref>
</sup>
</p>
<p>Teeguarden et al.<sup>
<xref ref-type="bibr" rid="bibr158-0960327112456316">158</xref>
<xref ref-type="bibr" rid="bibr159-0960327112456316"/>–<xref ref-type="bibr" rid="bibr160-0960327112456316">160</xref>
</sup> examined the kinetics of ingested Mn in rats and mice and provided explanations for the differences in metabolic handling between a single oral bolus and continuous high oral dosing. These differences account for the apparent inconsistencies between the single dose oral LD<sub>50</sub> values (225–1082 mg/kg) compared with the fact that repeated consumption of higher daily doses (1300–2251 mg/kg) failed to cause death. Normally, tissue Mn levels are regulated by intestinal uptake and hepatic elimination and other than relative solubility of the various Mn forms, these are the primary physiological factors that dictate proportional control of systemic Mn bioavailability. First, as the dietary Mn exposure increased the rate constant for Mn uptake from the intestine declined (~23-fold). Second, as the dietary Mn exposure increased, biliary elimination of Mn increased (~7-fold). However, in case of the Mn acute oral bolus (1000–10,000 mg/kg), systemic exposure is controlled by the amount of Mn delivered to the liver as contrast to the relatively small control contribution provided by the intestine. Thus, a high oral Mn bolus delivered over minutes to hours overwhelms existing physiologic Mn control processes, whereas the same dose ingested over several hours can be handled without adverse consequence due to normal intestinal and hepatic homeostatic Mn regulation.</p>
</sec>
<sec id="section16-0960327112456316">
<title>Genotoxicity</title>
<p>International Programme on Chemical Safety (IPCS)<sup>
<xref ref-type="bibr" rid="bibr93-0960327112456316">93</xref>
</sup> and Assem et al.<sup>
<xref ref-type="bibr" rid="bibr161-0960327112456316">161</xref>
</sup> reviewed the in vivo and in vitro genotoxicity data for KMnO<sub>4</sub> and related Mn compounds, including the sulfate and chloride salts. KMnO<sub>4</sub> has been associated with micronuclei or chromosomal aberrations in vivo<sup>
<xref ref-type="bibr" rid="bibr121-0960327112456316">121</xref>
</sup> or in vitro<sup>
<xref ref-type="bibr" rid="bibr162-0960327112456316">162</xref>
</sup> in some studies but not in others.<sup>
<xref ref-type="bibr" rid="bibr163-0960327112456316">163</xref>
</sup> The IPCS<sup>
<xref ref-type="bibr" rid="bibr93-0960327112456316">93</xref>
</sup> concluded that the results of in vitro studies show that some forms of Mn have mutagenic potential, but the results of in vivo studies in mammals are not consistent. Therefore, Assem et al.<sup>
<xref ref-type="bibr" rid="bibr161-0960327112456316">161</xref>
</sup> concluded that Mn might be ‘weakly mutagenic in vitro and possibly clastogenic in vivo but with unknown genotoxic effects in humans’.</p>
</sec>
<sec id="section17-0960327112456316">
<title>Risk characterization</title>
<p>Mn is an essential nutrient required for normal bone development, reproduction, and neurological function,<sup>
<xref ref-type="bibr" rid="bibr164-0960327112456316">164</xref>
</sup> where it is necessary for the activity of succinic dehydrogenase, hydrolases, kinases, decarboxylases, and transferases.<sup>
<xref ref-type="bibr" rid="bibr38-0960327112456316">38</xref>
</sup> Although isolated cases of Mn deficiency have been identified, there is no evidence that Mn deficiency is a public health problem in well-nourished populations and the usual dietary Mn intake (2–3 mg/day) appears adequate to meet nutritional requirements.<sup>
<xref ref-type="bibr" rid="bibr38-0960327112456316">38</xref>
</sup>
</p>
<p>The MnO<sub>4</sub>
<sup>−</sup> and Mn<sup>+2</sup> ions are oxidizing agents and direct contact with KMnO<sub>4</sub> either as the crystal or in concentrated aqueous solution can induce chemical burns of mucous membranes, the skin, the cornea, and ocular membranes.<sup>
<xref ref-type="bibr" rid="bibr113-0960327112456316">113</xref>,<xref ref-type="bibr" rid="bibr115-0960327112456316">115</xref>,<xref ref-type="bibr" rid="bibr165-0960327112456316">165</xref>
</sup> Direct contact with concentrated KMnO<sub>4</sub> induced oropharyngeal, esophageal, and gastric ulceration, hemorrhage, and perforation with subsequent development of structures and pyloric stenosis. Acute ingestion of sufficient quantities has caused death as a consequence of acute glottic and laryngeal edema and respiratory obstruction. Death following acute KMnO<sub>4</sub> ingestion is a consequence of gastrointestinal hemorrhage, cardiovascular collapse, profound hypotensive shock, and respiratory failure.<sup>
<xref ref-type="bibr" rid="bibr40-0960327112456316">40</xref>
</sup> When used as a local antiseptic, contact with relatively dilute KMnO<sub>4</sub> solutions is innocuous and the mild local irritation is said to be ‘self-limited’.<sup>
<xref ref-type="bibr" rid="bibr33-0960327112456316">33</xref>
</sup>
</p>
<p>Guilarte et al.<sup>
<xref ref-type="bibr" rid="bibr154-0960327112456316">154</xref>
</sup> presented data collected in macaques after repeated intravenous injections of 3.3–4.9 mg Mn/kg as MnSO<sub>4</sub> that yielded whole blood Mn concentrations of 14–106 μg/L, and observed that those values were consistent with circulating Mn measured in some human populations, including residents of Mn-mining districts.<sup>
<xref ref-type="bibr" rid="bibr166-0960327112456316">166</xref>
</sup> Guilarte et al.<sup>
<xref ref-type="bibr" rid="bibr154-0960327112456316">154</xref>
</sup> suggested that the deficits in fine motor skills and certain aspects of macaque cognitive function at those Mn levels may also occur in human beings. The Golub et al.<sup>
<xref ref-type="bibr" rid="bibr155-0960327112456316">155</xref>
</sup> study with Mn in soy formula found increased physical activity among Rhesus monkeys fed with 107.5 mg Mn/kg/day, but those subtle changes were within the normal range of the animal’s behavior and no adverse health outcomes were identified. The Gupta et al.<sup>
<xref ref-type="bibr" rid="bibr156-0960327112456316">156</xref>
</sup> trial with chronic oral MnCl<sub>2</sub> reported signs of central nervous system (CNS) toxicity, but the fact that only a single dose level was examined reduced the utility of that study.<sup>
<xref ref-type="bibr" rid="bibr157-0960327112456316">157</xref>
</sup> Thus, in the absence of empirical data from primate drinking water studies relative to parenteral injection and identification of relative source contribution to determine at what level of Mn ingestion via drinking water might produce local tissue damage or elevate blood Mn concentrations after either acute or chronic exposure, the nonhuman primate data are not helpful in establishing Mn limits in drinking water.</p>
<p>In humans, the consequences of excessive Mn exposure result from its actions in the CNS after repeated inhalation of Mn dusts and fume.<sup>
<xref ref-type="bibr" rid="bibr37-0960327112456316">37</xref>
</sup> Prolonged excessive Mn exposure is thought to increase substitution of Cu into normal CNS prion binding glycoproteins (PrP<sup>c</sup>) that are found on the surface of the neurons and glia. This substitution plays a role in conversion of those proteins to the pathogenic scrapie form (PrP<sup>Sc</sup>). The PrP<sup>Sc</sup> aggregates and serves as a template to convert more PrP<sup>c</sup> protein to the PrP<sup>Sc</sup> and the altered Mn<sup>+2</sup>, Cu<sup>+2</sup>, and Zn<sup>+2</sup> binding properties and increased Cu content reduce antioxidant capabilities and hasten the conversion of PrP<sup>C</sup> to PrP<sup>Sc</sup>. Once absorbed into neuronal cells, Mn depletes glutathione, increases the generation of reactive oxygen species as a result of its accumulation in mitochondria and inhibition of electron transport,<sup>
<xref ref-type="bibr" rid="bibr167-0960327112456316">167</xref>
</sup> activates caspase-3, and increases DNA fragmentation. Increased caspase-3 activity leading to DNA fragmentation and chromatin condensation are hallmarks of Mn-induced apoptotic cell death.<sup>
<xref ref-type="bibr" rid="bibr168-0960327112456316">168</xref>
</sup>
</p>
<p>Chronic high Mn exposures are neurotoxic, but chronic poisoning is almost always the result of inhaled Mn dusts or fumes rather than as a result of high dietary levels due to the fact that gastrointestinal bioavailability of Mn is comparatively low (~3%).<sup>
<xref ref-type="bibr" rid="bibr38-0960327112456316">38</xref>
</sup> However, in addition to the reports of acute KMnO<sub>4</sub> poisoning by Degner et al.<sup>
<xref ref-type="bibr" rid="bibr67-0960327112456316">67</xref>
</sup> and Holzgraefe et al.,<sup>
<xref ref-type="bibr" rid="bibr66-0960327112456316">66</xref>
</sup> there are accounts of repeated ingestion of Mn-contaminated water and development of manganism, but interpretation of those reports is problematic.<sup>
<xref ref-type="bibr" rid="bibr36-0960327112456316">36</xref>
</sup>
</p>
<p>There is considerable uncertainty attendant to health risk assessment of Mn exposure, a situation complicated by the fact it is an essential nutrient.<sup>
<xref ref-type="bibr" rid="bibr72-0960327112456316">72</xref>,<xref ref-type="bibr" rid="bibr145-0960327112456316">145</xref>,<xref ref-type="bibr" rid="bibr164-0960327112456316">164</xref>
</sup> Most of the studies in animals have been conducted in rodents where internal cumulative doses between 18 and 5300 mg/kg are associated with an increase in striatal γ-aminobutyric acid (GABA) and there are indications of a ‘variable’ effect on striatal dopamine at internal cumulative doses at 200 mg/kg or more.<sup>
<xref ref-type="bibr" rid="bibr91-0960327112456316">91</xref>,<xref ref-type="bibr" rid="bibr92-0960327112456316">92</xref>
</sup> Studies with nonhuman primates found mild deficits in working memory,<sup>
<xref ref-type="bibr" rid="bibr169-0960327112456316">169</xref>
</sup> motor deficits and changes in the globus pallidus after inhalation or acute<sup>
<xref ref-type="bibr" rid="bibr154-0960327112456316">154</xref>
</sup> or repeated parenteral exposure to MnSO<sub>4</sub>, MnCl<sub>2</sub>, or MnO<sub>2</sub> after internal cumulative doses between 3 and 1000 mg Mn/kg (<xref ref-type="table" rid="table2-0960327112456316">Table 3</xref>).</p>
<p>There have been suggestions that inhaled Mn from bathwater during showering may present a neurotoxic hazard,<sup>
<xref ref-type="bibr" rid="bibr170-0960327112456316">170</xref>
</sup> but others<sup>
<xref ref-type="bibr" rid="bibr171-0960327112456316">171</xref>
</sup> dismissed that as a speculation.</p>
</sec>
<sec id="section18-0960327112456316">
<title>Cancer characterization</title>
<p>Information on the carcinogenic potential of Mn is limited.<sup>
<xref ref-type="bibr" rid="bibr93-0960327112456316">93</xref>
</sup> Lifetime carcinogenicity/chronic toxicity bioassays have been conducted in mice and rats fed MnSO<sub>4</sub> at up to 731 and 232 mg Mn/kg/day, respectively. There was no evidence for increased tumors at any site in rats, but based on a marginal increase in thyroid follicular adenomas and hyperplasia in the high-dose mice, the NTP<sup>
<xref ref-type="bibr" rid="bibr128-0960327112456316">128</xref>
</sup> concluded that there was ‘equivocal’ evidence for MnSO<sub>4</sub>-induced carcinogenicity in mice.</p>
<p>The ATSDR<sup>
<xref ref-type="bibr" rid="bibr36-0960327112456316">36</xref>
</sup> concluded, ‘There is no evidence that manganese causes cancer in humans. Although no firm conclusion can be drawn from the mixed results in animal studies, there are little data to suggest inorganic manganese is carcinogenic. The EPA has provided manganese with a weight-of-evidence classification D – not classifiable as to human carcinogenicity.” Assem et al.<sup>
<xref ref-type="bibr" rid="bibr161-0960327112456316">161</xref>
</sup> considered the ‘rodent data do not provide any clear evidence that Mn exposure is carcinogenic and the epidemiologic evidence is at best equivocal’.</p>
</sec>
<sec id="section19-0960327112456316">
<title>Susceptible populations</title>
<p>The ingestion hazards of elevated Mn in drinking water have been examined in children<sup>
<xref ref-type="bibr" rid="bibr16-0960327112456316">16</xref>,<xref ref-type="bibr" rid="bibr81-0960327112456316">81</xref>,<xref ref-type="bibr" rid="bibr89-0960327112456316">89</xref>
</sup> and the elderly.<sup>
<xref ref-type="bibr" rid="bibr78-0960327112456316">78</xref>
</sup> There are suggestions of possible Mn-induced changes in behavior, but the nature of those reports does not permit definitive conclusions.<sup>
<xref ref-type="bibr" rid="bibr36-0960327112456316">36</xref>
</sup> Several studies concluded that people with chronic liver disease or those who are alcoholics may be at increased risk of Mn accumulation and manganism.<sup>
<xref ref-type="bibr" rid="bibr36-0960327112456316">36</xref>,<xref ref-type="bibr" rid="bibr91-0960327112456316">91</xref>,<xref ref-type="bibr" rid="bibr172-0960327112456316">172</xref>
<xref ref-type="bibr" rid="bibr173-0960327112456316"/>
<xref ref-type="bibr" rid="bibr174-0960327112456316"/>–<xref ref-type="bibr" rid="bibr175-0960327112456316">175</xref>
</sup> There are reports<sup>
<xref ref-type="bibr" rid="bibr59-0960327112456316">59</xref>
<xref ref-type="bibr" rid="bibr60-0960327112456316"/>–<xref ref-type="bibr" rid="bibr61-0960327112456316">61</xref>
</sup> that death after acute KMnO<sub>4</sub> ingestion was associated with hepatic failure.</p>
<p>KMnO<sub>4</sub> is an oxidizer and the corrosive hazards of KMnO<sub>4</sub> are well known, but no specific groups have been identified as uniquely sensitive to the hazards of mucous membrane or skin contact with or ingestion of KMnO<sub>4</sub> either as the solid or in solution.</p>
</sec>
<sec id="section20-0960327112456316">
<title>Exposure assessment</title>
<p>Ritter et al.<sup>
<xref ref-type="bibr" rid="bibr17-0960327112456316">17</xref>
</sup> compiled surface and groundwater concentration data and noted that not only is Mn an essential element but also the majority of human Mn exposure comes from food. Total dietary Mn consumption ranges from as low as 0.7–2 mg/day to as high as 8.8–10.9 mg/day (equivalent to 125–155 µg/kg/day for a 70-kg adult male) with the highest sources in nuts, tea, spices, cereals, fruits, and vegetables. Typical male American teenagers and adults consuming a 3900-cal diet ingest 3.8 and 3.7 mg/day, respectively.</p>
<p>After reviewing Mn concentrations in waters of North America, Ritter et al.<sup>
<xref ref-type="bibr" rid="bibr17-0960327112456316">17</xref>
</sup> concluded that routine concentrations ‘do not present any significant hazards for human life’. Drinking water typically contributes 11% of daily Mn intake, assuming that an adult consumes 2 L/day of drinking water that contains the typical concentrations found in US tap water (mean = 17–32 µg/L); this equates to a drinking water total Mn contribution between 40 and 64 µg/day. If one were to consume drinking water with Mn at 1320 µg/L, the contribution from water to total daily Mn exposure would be equivalent to that from the diet.<sup>
<xref ref-type="bibr" rid="bibr38-0960327112456316">38</xref>
</sup>
</p>
<p>Nevertheless, there are water systems and groundwater sources (typically from Mn-bearing minerals like pyrolusite and in situations where high carbonate, reducing conditions, low O<sub>2</sub>, and reduced pH predominate), where total Mn concentrations &gt;1000 µg/L are routine. In some surface waters, total Mn concentrations up to 3230 µg/L have been detected<sup>
<xref ref-type="bibr" rid="bibr38-0960327112456316">38</xref>
</sup> and in water with high organic content, Mn is adsorbed within suspended particulates. Loranger and Zayed<sup>
<xref ref-type="bibr" rid="bibr176-0960327112456316">176</xref>
</sup> concluded that consumption of such high levels of total Mn might contribute up to 20% of one’s daily total Mn intake. Wasserman et al.<sup>
<xref ref-type="bibr" rid="bibr89-0960327112456316">89</xref>
</sup> noted that 6% of US households use drinking water with Mn concentrations greater than the US EPA lifetime health advisory (300 µg Mn/L).<sup>
<xref ref-type="bibr" rid="bibr77-0960327112456316">77</xref>
</sup>
</p>
</sec>
</sec>
<sec id="section21-0960327112456316">
<title>Do not consume level derivation</title>
<sec id="section22-0960327112456316">
<title>Key studies and critical effects</title>
<p>Recognizing that Mn is an essential nutrient and that ingestion of concentrated KMnO<sub>4</sub> solutions can be lethal, review of the longer-term studies in rodents found that most were concerned with neurologic impairment (<xref ref-type="table" rid="table2-0960327112456316">Table 3</xref>). Since rodents are poor surrogates for Mn toxicity in primates<sup>
<xref ref-type="bibr" rid="bibr72-0960327112456316">72</xref>,<xref ref-type="bibr" rid="bibr77-0960327112456316">77</xref>,<xref ref-type="bibr" rid="bibr92-0960327112456316">92</xref>,<xref ref-type="bibr" rid="bibr116-0960327112456316">116</xref>,<xref ref-type="bibr" rid="bibr145-0960327112456316">145</xref>
</sup> and the primate data are limited to parenteral injection<sup>
<xref ref-type="bibr" rid="bibr92-0960327112456316">92</xref>,<xref ref-type="bibr" rid="bibr117-0960327112456316">117</xref>
</sup> or only single or relatively low dose levels<sup>
<xref ref-type="bibr" rid="bibr154-0960327112456316">154</xref>
<xref ref-type="bibr" rid="bibr155-0960327112456316"/>–<xref ref-type="bibr" rid="bibr156-0960327112456316">156</xref>
</sup> that do not elicit serious acute or irreversible adverse health effects, the available animal data with various inorganic Mn salts are not informative to derivation of an acute oral RfD for KMnO<sub>4</sub>.</p>
<p>There are many case reports that describe damage to the gastrointestinal tract, liver, and pancreas after acute ingestion of either crystalline or concentrated KMnO<sub>4</sub>. These reports are consistent in that a single dose of 15–20 g causes destruction of tissue that ‘was so extensive as to suggest alkali corrosive. Even dilute solutions may cause irritation to the stomach while concentrated solutions inflame the mucous membrane and may even induce gastroenteritis’.<sup>
<xref ref-type="bibr" rid="bibr56-0960327112456316">56</xref>
</sup> Study of people who use domestic tap water with comparatively high levels of Mn (610 µg/L,<sup>
<xref ref-type="bibr" rid="bibr81-0960327112456316">81</xref>
</sup> 1367 µg/L,<sup>
<xref ref-type="bibr" rid="bibr86-0960327112456316">86</xref>
</sup> 2100 µg/L,<sup>
<xref ref-type="bibr" rid="bibr79-0960327112456316">79</xref>
</sup> 2300 µg/L,<sup>
<xref ref-type="bibr" rid="bibr78-0960327112456316">78</xref>
</sup> 2700 µg/L,<sup>
<xref ref-type="bibr" rid="bibr82-0960327112456316">82</xref>
</sup> 3442 µg/L,<sup>
<xref ref-type="bibr" rid="bibr84-0960327112456316">84</xref>
</sup> and 3908 µg/L<sup>
<xref ref-type="bibr" rid="bibr89-0960327112456316">89</xref>
</sup>) could provide indications of concentrations that are intolerable, but like the Bouchard et al. studies<sup>
<xref ref-type="bibr" rid="bibr81-0960327112456316">81</xref>,<xref ref-type="bibr" rid="bibr82-0960327112456316">82</xref>
</sup> where 33–91% of the participants did not drink tap water containing 500–2700 µg Mn/L, it is not clear that other groups actually consumed the affected water since Mn concentrations &gt;50 µg/L have a pink to purple color and unpleasant taste.<sup>
<xref ref-type="bibr" rid="bibr16-0960327112456316">16</xref>
</sup>
</p>
<p>Other than the absence of oropharyngeal irritation after rinsing the mouth twice daily with 100 mg/L aqueous<sup>
<xref ref-type="bibr" rid="bibr65-0960327112456316">65</xref>
</sup> KMnO<sub>4</sub> and death after consumption of &gt;10 g,<sup>
<xref ref-type="bibr" rid="bibr45-0960327112456316">45</xref>,<xref ref-type="bibr" rid="bibr58-0960327112456316">58</xref>
<xref ref-type="bibr" rid="bibr59-0960327112456316"/>–<xref ref-type="bibr" rid="bibr60-0960327112456316">60</xref>,<xref ref-type="bibr" rid="bibr57-0960327112456316">57</xref>
</sup> there are four reports that represent potential short-term key observations. Repeated (3–4 times at 1 h intervals) oral lavage of intoxicated (and apparently fasted) patients with ≥1350 mg/L of pH-adjusted aqueous KMnO<sub>4</sub> caused local irritation, inflammation, and vomiting.<sup>
<xref ref-type="bibr" rid="bibr62-0960327112456316">62</xref>
<xref ref-type="bibr" rid="bibr63-0960327112456316"/>–<xref ref-type="bibr" rid="bibr64-0960327112456316">64</xref>
</sup> Among 13 adults (ages 16–34 years) who ingested a single median KMnO<sub>4</sub> dose of 1200 mg (17–20 mg/kg), 73% experienced epigastric pain, nausea, and vomiting and 27% complained of generalized weakness and headache; one developed skin burns, but none exhibited laryngeal edema and none died. Some 37% of these patients dissolved the material in water while the remainder ingested it as a solid.<sup>
<xref ref-type="bibr" rid="bibr52-0960327112456316">52</xref>
</sup> Despite the caustic and irritant properties of concentrated KMnO<sub>4</sub> in humans, the response can vary in that some apparently tolerate ingestion of 8% KMnO<sub>4</sub> (80 mg/mL equivalent to ~10 g in a 125-mL water or 150 mg/kg),<sup>
<xref ref-type="bibr" rid="bibr66-0960327112456316">66</xref>
</sup> whereas others who consumed aqueous KMnO<sub>4</sub> at 300–500 mg (equivalent to 1300–2200 mg/L or/and 5–7.5 mg/kg) experienced local irritation and repetitive emesis (apparently on an empty stomach) or no ill effect (on a full stomach).<sup>
<xref ref-type="bibr" rid="bibr63-0960327112456316">63</xref>,<xref ref-type="bibr" rid="bibr64-0960327112456316">64</xref>
</sup>
</p>
<p>Considering the clinical reports together shows that humans vomit after consuming KMnO<sub>4</sub> in water at &gt;1000 mg/L but tolerate repeated direct oral contact with dilute (100 mg/L) solutions of KMnO<sub>4</sub>. Although oral rinsing with dilute KMnO<sub>4</sub> is routine clinical practice in some hospitals,<sup>
<xref ref-type="bibr" rid="bibr65-0960327112456316">65</xref>
</sup> no controlled concentration–response studies that assessed potential toxicity associated with oral KMnO<sub>4</sub> rinsing were identified and no information was located to confirm that oral contact with 100 mg/L KMnO<sub>4</sub> represents a definitive NOAEL. Since clinical experience with acute oral administration of aqueous KMnO<sub>4</sub> best predicts the acute toxicity of KMnO<sub>4</sub> in drinking water (as contrast to ingestion of crystalline KMnO<sub>4</sub>),<sup>
<xref ref-type="bibr" rid="bibr46-0960327112456316">46</xref>,<xref ref-type="bibr" rid="bibr51-0960327112456316">51</xref>,<xref ref-type="bibr" rid="bibr57-0960327112456316">57</xref>
</sup> an acute oral RfD can be based on local irritation and inflammation<sup>
<xref ref-type="bibr" rid="bibr31-0960327112456316">31</xref>,<xref ref-type="bibr" rid="bibr32-0960327112456316">32</xref>,<xref ref-type="bibr" rid="bibr177-0960327112456316">177</xref>
</sup> that precede the epigastric pain, nausea, and vomiting<sup>
<xref ref-type="bibr" rid="bibr52-0960327112456316">52</xref>,<xref ref-type="bibr" rid="bibr62-0960327112456316">62</xref>
<xref ref-type="bibr" rid="bibr63-0960327112456316"/>–<xref ref-type="bibr" rid="bibr64-0960327112456316">64</xref>
</sup> after ingestion of aqueous KMnO<sub>4</sub> seen after oral doses at 4–20 mg/kg.</p>
</sec>
<sec id="section23-0960327112456316">
<title>Dose-response</title>
<p>The acute ingestion hazard posed by KMnO<sub>4</sub> in aqueous solution is primarily a function of its oxidant properties.<sup>
<xref ref-type="bibr" rid="bibr36-0960327112456316">36</xref>,<xref ref-type="bibr" rid="bibr93-0960327112456316">93</xref>
</sup> Permanganic acid is a mineral acid that after ingestion of sufficiently high concentrations can cause immediate, life-threatening local corrosive tissue damage and can cause death due to asphyxiation. However, it is difficult to determine the minimum human fatal dose as often the quantity is either not known,<sup>
<xref ref-type="bibr" rid="bibr50-0960327112456316">50</xref>,<xref ref-type="bibr" rid="bibr59-0960327112456316">59</xref>
</sup> speculative (e.g. 5–10 g),<sup>
<xref ref-type="bibr" rid="bibr46-0960327112456316">46</xref>,<xref ref-type="bibr" rid="bibr60-0960327112456316">60</xref>
</sup> or not reported at all. In other cases, prompt emesis occurs and at least some of the ingested material is eliminated thus reducing the amount and residence time in the gut.<sup>
<xref ref-type="bibr" rid="bibr51-0960327112456316">51</xref>,<xref ref-type="bibr" rid="bibr52-0960327112456316">52</xref>,<xref ref-type="bibr" rid="bibr62-0960327112456316">62</xref>
<xref ref-type="bibr" rid="bibr63-0960327112456316"/>–<xref ref-type="bibr" rid="bibr64-0960327112456316">64</xref>
</sup> While KMnO<sub>4</sub> concentrations greater than 1:5000 (200 mg/L) are irritating to mucous membranes,<sup>
<xref ref-type="bibr" rid="bibr31-0960327112456316">31</xref>,<xref ref-type="bibr" rid="bibr32-0960327112456316">32</xref>,<xref ref-type="bibr" rid="bibr177-0960327112456316">177</xref>
</sup> the limited quantitative data in humans allow only approximations of dose–response for acute oral KMnO<sub>4</sub>. Direct mucous membrane contact with water containing KMnO<sub>4</sub> at 100 mg/L appears innocuous,<sup>
<xref ref-type="bibr" rid="bibr65-0960327112456316">65</xref>
</sup> direct contact with 200 mg/L causes mucosal irritation,<sup>
<xref ref-type="bibr" rid="bibr31-0960327112456316">31</xref>,<xref ref-type="bibr" rid="bibr32-0960327112456316">32</xref>,<xref ref-type="bibr" rid="bibr177-0960327112456316">177</xref>
</sup> intubation of ~1350–2200 mg/L in water elicits oral irritation, inflammation, and vomiting (equivalent to 3.7–9.2 mg/kg),<sup>
<xref ref-type="bibr" rid="bibr62-0960327112456316">62</xref>
<xref ref-type="bibr" rid="bibr63-0960327112456316"/>–<xref ref-type="bibr" rid="bibr64-0960327112456316">64</xref>
</sup> single ingestion of 17–20 mg/kg causes gastric pain, nausea, and vomiting<sup>
<xref ref-type="bibr" rid="bibr52-0960327112456316">52</xref>
</sup> and ingestion of 20–25 g (~300–400 mg/kg) causes immediate tissue destruction, life-threatening symptoms,<sup>
<xref ref-type="bibr" rid="bibr51-0960327112456316">51</xref>,<xref ref-type="bibr" rid="bibr56-0960327112456316">56</xref>,<xref ref-type="bibr" rid="bibr58-0960327112456316">58</xref>
</sup> and death.<sup>
<xref ref-type="bibr" rid="bibr45-0960327112456316">45</xref>
</sup>
</p>
</sec>
<sec id="section24-0960327112456316">
<title>Uncertainty factor selection</title>
<p>The following uncertainty factors were applied to the lowest concentration of KMnO<sub>4</sub> (200 mg/L) above which mucous membrane irritation,<sup>
<xref ref-type="bibr" rid="bibr31-0960327112456316">31</xref>,<xref ref-type="bibr" rid="bibr32-0960327112456316">32</xref>,<xref ref-type="bibr" rid="bibr177-0960327112456316">177</xref>
</sup> nausea and vomiting,<sup>
<xref ref-type="bibr" rid="bibr52-0960327112456316">52</xref>
</sup> oropharyngeal, esophageal, and gastric injury<sup>
<xref ref-type="bibr" rid="bibr62-0960327112456316">62</xref>
<xref ref-type="bibr" rid="bibr63-0960327112456316"/>–<xref ref-type="bibr" rid="bibr64-0960327112456316">64</xref>
</sup> occur.</p>
<sec id="section25-0960327112456316">
<title>Interspecies extrapolation (1×)</title>
<p>Since clinical experience<sup>
<xref ref-type="bibr" rid="bibr31-0960327112456316">31</xref>,<xref ref-type="bibr" rid="bibr32-0960327112456316">32</xref>,<xref ref-type="bibr" rid="bibr52-0960327112456316">52</xref>,<xref ref-type="bibr" rid="bibr62-0960327112456316">62</xref>
<xref ref-type="bibr" rid="bibr63-0960327112456316"/>–<xref ref-type="bibr" rid="bibr64-0960327112456316">64</xref>
</sup> serves as the basis for an acute oral RfD, an interspecies uncertainty factor of 1× was assigned.</p></sec>
<sec id="section26-0960327112456316">
<title>Intraspecies extrapolation (10×)</title>
<p>Impaired hepatic function results in reduced capacity to eliminate Mn in bile. An intraspecies uncertainty factor of 10× was assigned based on reports that newborn rats are more susceptible to ingested Mn than adult rats<sup>
<xref ref-type="bibr" rid="bibr151-0960327112456316">151</xref>
</sup> and reports linking chronic liver disease with increased Mn in blood and peripheral tissues.<sup>
<xref ref-type="bibr" rid="bibr36-0960327112456316">36</xref>
</sup> People with preexisting liver disease and those deficient in iron are at increased risk of Mn accumulation and encephalopathy.<sup>
<xref ref-type="bibr" rid="bibr36-0960327112456316">36</xref>,<xref ref-type="bibr" rid="bibr93-0960327112456316">93</xref>,<xref ref-type="bibr" rid="bibr117-0960327112456316">117</xref>,<xref ref-type="bibr" rid="bibr172-0960327112456316">172</xref>
<xref ref-type="bibr" rid="bibr173-0960327112456316"/>
<xref ref-type="bibr" rid="bibr174-0960327112456316"/>–<xref ref-type="bibr" rid="bibr175-0960327112456316">175</xref>
</sup>
</p>
</sec>
<sec id="section27-0960327112456316">
<title>LOAEL to NOAEL extrapolation (3×)</title>
<p>A LOAEL to NOAEL extrapolation factor of 3× was applied since the concentration associated with tissue irritation<sup>
<xref ref-type="bibr" rid="bibr166-0960327112456316">166</xref>
</sup> and corrosive response (200 mg/L)<sup>
<xref ref-type="bibr" rid="bibr31-0960327112456316">31</xref>,<xref ref-type="bibr" rid="bibr32-0960327112456316">32</xref>
</sup> is twice the concentration that failed to elicit local irritation based on repeated oral applications.<sup>
<xref ref-type="bibr" rid="bibr65-0960327112456316">65</xref>
</sup> The total uncertainty factor assigned for acute KMnO<sub>4</sub> ingestion is, therefore, 30×.</p>
</sec>
</sec>
<sec id="section28-0960327112456316">
<title>Acute oral RfD derivation</title>
<p>An acute RfD can be calculated based on the concentration associated with tissue irritation (1: 5000 mL equivalent 1 mg/5 mL or 200 mg/L)<sup><xref ref-type="bibr" rid="bibr31-0960327112456316">31</xref></sup>
<sup>,</sup>
<sup><xref ref-type="bibr" rid="bibr32-0960327112456316">32</xref></sup>
<sup>,</sup>
<sup><xref ref-type="bibr" rid="bibr177-0960327112456316">177</xref></sup> above which nausea, vomiting, and epigastric pain are seen</p>
<disp-formula id="disp-formula1-0960327112456316">
<mml:math id="mml-disp1-0960327112456316"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">R</mml:mi><mml:mi mathvariant="normal">f</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:mrow><mml:mtable columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mo stretchy="false">=</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">E</mml:mi><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">U</mml:mi><mml:mi mathvariant="normal">F</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mo stretchy="false">=</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mn>200</mml:mn><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thickmathspace"/><mml:msub><mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">O</mml:mi></mml:mrow></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:mn>30</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo stretchy="false">=</mml:mo><mml:mn>6.7</mml:mn><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thickmathspace"/><mml:msub><mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">O</mml:mi></mml:mrow></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo stretchy="false">=</mml:mo><mml:mn>7</mml:mn><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thickmathspace"/><mml:msub><mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">O</mml:mi></mml:mrow></mml:mrow><mml:mn>4</mml:mn></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">d</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:mfenced></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math>
<graphic alternate-form-of="disp-formula1-0960327112456316" xlink:href="10.1177_0960327112456316-eq1.tif"/>
</disp-formula>
<p>Using the ratio of Mn/KMnO<sub>4</sub> molecular weights (55/158) applied to an acute oral RfD of 6.7 mg/L for KMnO<sub>4</sub>, the acute RfD expressed as total Mn is</p>
<disp-formula id="disp-formula2-0960327112456316">
<mml:math id="mml-disp2-0960327112456316"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">C</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mtext mathvariant="normal"> </mml:mtext><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mtext mathvariant="normal"> </mml:mtext><mml:mi mathvariant="normal">R</mml:mi><mml:mi mathvariant="normal">f</mml:mi><mml:mi mathvariant="normal">D</mml:mi><mml:mo mathvariant="normal" stretchy="false">=</mml:mo><mml:mn mathvariant="normal">2</mml:mn><mml:mtext mathvariant="normal"> </mml:mtext><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mi mathvariant="normal">L</mml:mi><mml:mtext mathvariant="normal"> </mml:mtext><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo mathvariant="normal" stretchy="false">(</mml:mo><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mo mathvariant="normal" stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math>
<graphic alternate-form-of="disp-formula2-0960327112456316" xlink:href="10.1177_0960327112456316-eq2.tif"/>
</disp-formula>
<p>The acute oral RfD calculated here can be compared with the observation of acute manganism that became evident in one man at 2 weeks after he consumed 10,000 mg Mn over the preceding 4 weeks<sup><xref ref-type="bibr" rid="bibr66-0960327112456316">66</xref></sup> and to the report of chronic manganism associated with consuming well water containing 14 mg Mn<sub>3</sub>O<sub>4</sub>.<sup><xref ref-type="bibr" rid="bibr76-0960327112456316">76</xref></sup> In the former case, the total dose was 360 mg/day (or 5.1 mg/kg/day as KMnO<sub>4</sub> for a 70-kg adult); based on a 10-kg body weight and 1 L/day water consumption of a child, this equates ~51 mg/L KMnO<sub>4</sub> or 18 mg/L Mn. In the latter case, the total daily dose (20 mg Mn<sub>3</sub>O<sub>4</sub>/day) was estimated<sup><xref ref-type="bibr" rid="bibr38-0960327112456316">38</xref></sup> at ~0.3 mg Mn<sub>3</sub>O<sub>4</sub>/kg/day for a 70-kg adult or 0.2 mg Mn/kg/day.</p>
</sec>
</sec>
<sec id="section29-0960327112456316">
<title>Do not consume limit</title>
<p>The Do Not Consume Limit is equal to the acute oral RfD. The Do Not Consume Limit is expressed as a concentration rather than on a body weight basis since the critical effect was damage to mucous membranes and contact irritation as contrast to systemic toxicity.</p>
<disp-formula id="disp-formula3-0960327112456316">
<mml:math id="mml-disp3-0960327112456316"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">D</mml:mi><mml:mi mathvariant="normal">o</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:mrow></mml:mrow><mml:mtable columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mrow><mml:mo stretchy="false">=</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">R</mml:mi><mml:mi mathvariant="normal">f</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo stretchy="false">=</mml:mo><mml:mn>7</mml:mn><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thickmathspace"/><mml:msub><mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">O</mml:mi></mml:mrow></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo stretchy="false">=</mml:mo><mml:mn>2</mml:mn><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math>
<graphic alternate-form-of="disp-formula3-0960327112456316" xlink:href="10.1177_0960327112456316-eq3.tif"/>
</disp-formula>
</sec>
<sec id="section30-0960327112456316">
<title>Do Not Use level derivation: dermal</title>
<sec id="section31-0960327112456316">
<title>Key study and critical effect</title>
<p>An acute dermal RfV for KMnO<sub>4</sub> can be based on the fact that KMnO<sub>4</sub> is used at 100 mg/L as a direct soak antiseptic to treat various dermatological conditions.<sup>
<xref ref-type="bibr" rid="bibr33-0960327112456316">33</xref>
<xref ref-type="bibr" rid="bibr34-0960327112456316"/>–<xref ref-type="bibr" rid="bibr35-0960327112456316">35</xref>
</sup> There are accounts in which the contact with 100 mg/L is not irritating to the skin or mucous membranes after a 10-min application to treat dermatitis, dermatomycoses, and snakebite.<sup>
<xref ref-type="bibr" rid="bibr177-0960327112456316">177</xref>
</sup> Repeated irrigation of the urethra with 1:5000 or 1:2000 dilutions was said to elicit ‘slight’ mucosal irritation,<sup>
<xref ref-type="bibr" rid="bibr31-0960327112456316">31</xref>
</sup> but contact with higher concentrations (&gt;1:5000 equivalent to &gt;200 mg/L) or prolonged or repeated exposures are irritating.<sup>
<xref ref-type="bibr" rid="bibr32-0960327112456316">32</xref>
</sup>
</p>
</sec>
<sec id="section32-0960327112456316">
<title>Dose-response</title>
<p>While there are many accounts of damage after direct KMnO<sub>4</sub> contact with the skin and mucous membranes, rigorous dose–response relationships associated with topical exposure to KMnO<sub>4</sub> are difficult to establish due to the lack of controlled trials examining duration, frequency, and magnitude of exposure. Data are extensive for the other common Mn salts, but the toxicological profile and chemical properties of permanganic acid are so different from those of the carbonate, chloride, oxide, tetroxide, and related congeners that little can be learned about acute KMnO<sub>4</sub> toxicology from studies with other common Mn compounds. A robust database also exists concerning inhaled Mn dusts and fume,<sup>
<xref ref-type="bibr" rid="bibr36-0960327112456316">36</xref>
</sup> but the clinical experience with KMnO<sub>4</sub> indicates that reports of adverse health effects after chronic exposures to Mn dusts and fume offer little insight into potential health consequences of elevated Mn as a result of KMnO<sub>4</sub> present in drinking water.</p>
<p>A great many reports show that direct contact with aqueous KMnO<sub>4</sub> on mucous membranes caused caustic burns and at least in one instance caused death,<sup>
<xref ref-type="bibr" rid="bibr112-0960327112456316">112</xref>
</sup> but others state that humans tolerated either repeat oral contact with an 8% solution<sup>
<xref ref-type="bibr" rid="bibr66-0960327112456316">66</xref>
</sup> or repeated direct application of 0.05 to 0.5–1.0% solutions.<sup>
<xref ref-type="bibr" rid="bibr31-0960327112456316">31</xref>,<xref ref-type="bibr" rid="bibr32-0960327112456316">32</xref>
</sup> Other than those accounts and the fact that 0.01–1.0% KMnO<sub>4</sub> is used as a topical astringent, there are no topical concentration–response data available in the open literature.</p>
</sec>
<sec id="section33-0960327112456316">
<title>Uncertainty factor selection: dermal</title>
<p>The following uncertainty factors were applied to the clinical experience with 1:10,000 solutions (100 mg/L) KMnO<sub>4</sub> used as a direct soak antiseptic to treat various dermatological conditions including those in children.<sup>
<xref ref-type="bibr" rid="bibr33-0960327112456316">33</xref>
<xref ref-type="bibr" rid="bibr34-0960327112456316"/>–<xref ref-type="bibr" rid="bibr35-0960327112456316">35</xref>,<xref ref-type="bibr" rid="bibr113-0960327112456316">113</xref>,<xref ref-type="bibr" rid="bibr177-0960327112456316">177</xref>
</sup>
</p>
<sec id="section34-0960327112456316">
<title>Interspecies extrapolation (1×)</title>
<p>There is no evidence that percutaneous uptake of Mn through intact skin from KMnO<sub>4</sub> dissolved in dilute aqueous solution can influence the total body Mn burden. Since clinical experience in humans<sup>
<xref ref-type="bibr" rid="bibr33-0960327112456316">33</xref>
<xref ref-type="bibr" rid="bibr34-0960327112456316"/>–<xref ref-type="bibr" rid="bibr35-0960327112456316">35</xref>,<xref ref-type="bibr" rid="bibr113-0960327112456316">113</xref>,<xref ref-type="bibr" rid="bibr177-0960327112456316">177</xref>
</sup> serves as the basis of the dermal RfV, an interspecies uncertainty factor of unity was applied.</p>
</sec>
<sec id="section35-0960327112456316">
<title>Intraspecies extrapolation (1×)</title>
<p>An intraspecies uncertainty factor of unity was applied since patients with dermatologic conditions served as the basis of the dermal RfV. People with disease or damaged skin were considered to represent a sensitive subpopulation and children were among those treated with direct soak applications.<sup>
<xref ref-type="bibr" rid="bibr33-0960327112456316">33</xref>,<xref ref-type="bibr" rid="bibr113-0960327112456316">113</xref>
</sup>
</p>
</sec>
<sec id="section36-0960327112456316">
<title>LOAEL to NOAEL extrapolation (1×)</title>
<p>Because no signs of corrosion were observed during or after therapeutic application of KMnO<sub>4</sub> solutions as a topical astringent and antiseptic, the 0.01% (100 mg/L) solution can be considered a NOAEL. This factor is supported by the 7-day repeat application study by Stalder et al.<sup>
<xref ref-type="bibr" rid="bibr33-0960327112456316">33</xref>
</sup> in which repeated topical KMnO<sub>4</sub> treatment at 1:20,000 (50 mg/L) for 7 days resulted in local irritation in 2 of 10 children with preexisting atopic dermatitis.</p>
<p>The total uncertainty factor for dermal exposure is, therefore, 1×.</p>
</sec>
</sec>
<sec id="section37-0960327112456316">
<title>Acute dermal RfV calculation</title>
<p>An acute dermal RfV based on the KMnO<sub>4</sub> concentration used to treat dermatitis, ringworm, and other skin conditions is calculated as follows</p>
<disp-formula id="disp-formula4-0960327112456316">
<mml:math id="mml-disp4-0960327112456316"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">D</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">R</mml:mi><mml:mi mathvariant="normal">f</mml:mi><mml:mi mathvariant="normal">V</mml:mi></mml:mrow></mml:mrow><mml:mtable columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mrow><mml:mo stretchy="false">=</mml:mo><mml:mrow><mml:mfrac><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">N</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">E</mml:mi><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:mstyle><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">U</mml:mi><mml:mi mathvariant="normal">F</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo stretchy="false">=</mml:mo><mml:mrow><mml:mfrac><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mn>100</mml:mn><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thickmathspace"/><mml:msub><mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">O</mml:mi></mml:mrow></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:mstyle><mml:mn>1</mml:mn></mml:mfrac></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo stretchy="false">=</mml:mo><mml:mn>100</mml:mn><mml:mspace width="thickmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thickmathspace"/><mml:msub><mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">O</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:mn mathvariant="normal">4</mml:mn></mml:mrow></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math>
<graphic alternate-form-of="disp-formula4-0960327112456316" xlink:href="10.1177_0960327112456316-eq4.tif"/>
</disp-formula>
<p>Using the ratio molecular weight Mn/molecular weight KMnO<sub>4</sub> (55/158), the acute dermal RfV = 34.8 mg/L for Mn and 30 mg/L for Mn (rounded)</p>
</sec>
</sec>
<sec id="section38-0960327112456316">
<title>Do Not Use limit: dermal</title>
<p>The Do Not Use limit – dermal is the same as the acute dermal RfV, since both are expressed as concentration.</p>
<disp-formula id="disp-formula5-0960327112456316">
<mml:math id="mml-disp5-0960327112456316"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">D</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mtext mathvariant="normal"> </mml:mtext><mml:mi mathvariant="normal">N</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mtext mathvariant="normal"> </mml:mtext><mml:mi mathvariant="normal">U</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:mrow></mml:mrow><mml:mtable columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mrow><mml:mrow><mml:mrow><mml:mo mathvariant="normal" stretchy="false">=</mml:mo><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mtext mathvariant="normal"> </mml:mtext><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mtext mathvariant="normal"> </mml:mtext><mml:mi mathvariant="normal">R</mml:mi><mml:mi mathvariant="normal">f</mml:mi><mml:mi mathvariant="normal">V</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mrow><mml:mrow><mml:mo mathvariant="normal" stretchy="false">=</mml:mo><mml:mn mathvariant="normal">100</mml:mn><mml:mtext mathvariant="normal"> </mml:mtext><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mi mathvariant="normal">L</mml:mi><mml:mtext mathvariant="normal"> </mml:mtext><mml:mi mathvariant="normal">K</mml:mi><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">O</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:mn mathvariant="normal">4</mml:mn></mml:mrow></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow><mml:mrow><mml:mo mathvariant="normal" stretchy="false">=</mml:mo><mml:mn mathvariant="normal">30</mml:mn><mml:mtext mathvariant="normal"> </mml:mtext><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mi mathvariant="normal">L</mml:mi><mml:mtext mathvariant="normal"> </mml:mtext><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo mathvariant="normal" stretchy="false">(</mml:mo><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mo mathvariant="normal" stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math>
<graphic alternate-form-of="disp-formula5-0960327112456316" xlink:href="10.1177_0960327112456316-eq5.tif"/>
</disp-formula>
</sec>
<sec id="section39-0960327112456316">
<title>Do Not Use limit derivation – ocular</title>
<p>Although direct contact with crystalline KMnO<sub>4</sub> caused ocular damage<sup>
<xref ref-type="bibr" rid="bibr102-0960327112456316">102</xref>,<xref ref-type="bibr" rid="bibr153-0960327112456316">153</xref>
</sup> clinical accounts of ocular contact with aqueous KMnO<sub>4</sub> solutions were limited to one case report<sup>
<xref ref-type="bibr" rid="bibr103-0960327112456316">103</xref>
</sup> in which a man splashed a concentrated (but unspecified) KMnO<sub>4</sub> solution into both eyes. Recognizing that the cornea may be more sensitive than mucous membranes to KMnO<sub>4</sub>, there are no data upon which to base an acute ocular RfV.</p>
</sec>
<sec id="section40-0960327112456316">
<title>Other standards and guidelines</title>
<p>Assuming the 70-kg adult consumes 2 L of drinking water each day and the 10-kg child consumes 1 L/day, the daily Mn dose received at the 2 mg/L acute oral RfD calculated here is equivalent to 0.06 and 0.2 mg/kg/day, respectively. The US NRC<sup>
<xref ref-type="bibr" rid="bibr178-0960327112456316">178</xref>
</sup> concluded the ‘estimated safe and adequate daily dietary intake’ of Mn was 0.3–0.6 mg for infants aged 6 months, 0.6–1.0 mg for infants aged 6–12 months, 1.0–1.5 mg for children aged 1–3 years, 1.5–2.0 mg for children aged 4–6 years, and 2.0–5.0 mg for adults, values equivalent to 0.15–0.2 mg/day for the 10-kg child and 0.03–0.08 mg/day for the 60-kg woman. In 2001, the Food and Nutrition Board, Institute of Medicine,<sup>
<xref ref-type="bibr" rid="bibr179-0960327112456316">179</xref>
</sup> revised the value for newborns to 6 months of age as 0.003 mg/day. As age increased, the recommended intakes increased to 2.3 mg/day for adult males and up to 2.6 mg/day for lactating mothers. Thus, ingestion of drinking water at the 2 mg/L Do Not Consume level represents 100% of the child’s daily required Mn and 40–100% of the adult’s daily required Mn.</p>
<p>Taking into account consumption of grains, beverages (including tea), and vegetables, those sources provide only 70% of the Mn required each day for adult males and females,<sup>
<xref ref-type="bibr" rid="bibr180-0960327112456316">180</xref>
</sup> yet no case of Mn deficiency in human beings has ever been described.<sup>
<xref ref-type="bibr" rid="bibr181-0960327112456316">181</xref>
</sup> Nevertheless, the US EPA<sup>
<xref ref-type="bibr" rid="bibr77-0960327112456316">77</xref>
</sup> adopted 0.14 mg/kg/day as an oral RfD for all forms of Mn and recommended adoption of a 10-day health advisory of 1 mg Mn/L as a 1-day exposure limit. The US EPA based the 10-day health advisory on ‘the upper end of the adequate intake for a 10 kg child (up to 1 mg/day)’ and considered the 1 mg/L as protective for adults (including the elderly and those with liver disease who may experience impaired biliary excretion). For infants younger than 6 months, the US EPA advised that the lifetime Mn health advisory for Mn of 0.3 mg/L be used even for acute exposures of 10 days ‘because of the concerns for differences in manganese content in human milk and formula and the possibility of higher absorption and lower excretion in young infants’.</p>
<p>The Do Not Consume limit is twice the US EPA<sup>
<xref ref-type="bibr" rid="bibr77-0960327112456316">77</xref>
</sup> 1 mg/L 10-day Health Advisory of 1 mg/L for an adult, and almost seven times the Lifetime Health Advisory of 0.3 mg/L recommended for short-term exposures for an infant less than 6 months of age. The Do Not Consume limit is 40-fold higher than the 0.05 mg/L secondary maximum contaminant level, which is a ‘reasonable goal for drinking water quality’ that is intended to control black to brown discoloration, black staining, and bitter metallic taste (40 CFR 143.3). Although people have apparently acclimated to drinking water containing up to 2.16 mg Mn/L<sup>
<xref ref-type="bibr" rid="bibr78-0960327112456316">78</xref>
</sup> water, elevated Mn in water may not be tolerated by those who are not accustomed to its metallic taste.</p>
</sec>
<sec id="section41-0960327112456316">
<title>Conclusion</title>
<p>The Do Not Consume and Do Not Use levels derived above are designed to aid water purveyors and regulatory officials in emergency planning. The Do Not Consume concentration is ~200–300 times less than the KMnO<sub>4</sub> concentrations that can cause immediate symptoms in the human gastrointestinal tract.<sup>
<xref ref-type="bibr" rid="bibr62-0960327112456316">62</xref>
<xref ref-type="bibr" rid="bibr63-0960327112456316"/>–<xref ref-type="bibr" rid="bibr64-0960327112456316">64</xref>
</sup> Consumption of 2 L of water at the Do Not Consume concentration is equivalent to 4 mg Mn/day or 36% of the 11 mg tolerable daily upper intake level.<sup>
<xref ref-type="bibr" rid="bibr179-0960327112456316">179</xref>
</sup> As no quantitative ocular toxicity data were located, a Do Not Use level for KMnO<sub>4</sub> to prevent ocular injury could be based on pH; solutions with a pH less than 2.0 are considered corrosive in the eye<sup>
<xref ref-type="bibr" rid="bibr182-0960327112456316">182</xref>
<xref ref-type="bibr" rid="bibr183-0960327112456316"/>–<xref ref-type="bibr" rid="bibr184-0960327112456316">184</xref>
</sup> and complaints of ocular irritation tend to increase as solution pH declines.<sup>
<xref ref-type="bibr" rid="bibr185-0960327112456316">185</xref>
</sup> Even at KMnO<sub>4</sub> concentrations substantially higher (500 mg KMnO<sub>4</sub>/L or 174 mg Mn/L) than the limits derived here, the pH of KMnO<sub>4</sub> in distilled water (<xref ref-type="table" rid="table1-0960327112456316">Table 2</xref>) is greater than that considered corrosive by regulatory agencies.</p>
<p>The pH of drinking water with elevated KMnO<sub>4</sub> can be less (<xref ref-type="table" rid="table1-0960327112456316">Table 2</xref>) than that normally considered acceptable (6.5–8.5) range (40 CFR 143.3). Since water with Mn concentrations greater than 0.05 mg/L (40 CFR 143.3) has a pink to purple tint with a bitter or metallic taste and it stains fabrics and other porous materials, the concentrations derived here are most likely self-limiting. To utilize the values derived here, emergency response plans should account for the KMnO<sub>4</sub> exposure scenario and the pH of the water as well as the public health and safety consequences associated with cautions placed on use of municipal water.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="other" id="fn1-0960327112456316">
<label>Authors’ Note</label>
<p>Mention of trade names, proprietary products, or specific equipment does not constitute an endorsement by NSF International, neither does it imply that other products may not be equally suitable. The drinking water Do Not Consume/Do Not Use limits derived here are based on examination of the toxicity of specific materials in mammalian systems. These limits are designed to protect the public from short-term adverse health effects associated with either ingestion or other direct contact (skin and eye) during bathing and showering. As such, beneficial uses of water intended for other than domestic use (e.g. firefighting, landscape or agricultural irrigation, sanitary or storm sewers, industrial process waters, and hemodialysis) are not considered here and the Do Not Consume/Do Not Use limits should not be applied to exposure situations other than potable water or to species other than mammals.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0960327112456316">
<label>Funding</label>
<p>NSF International gratefully acknowledges financial support from the State of Pennsylvania Department of Environmental Protection.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgment</title>
<p>ANSF International is indebted to the volunteer members of its Health Advisory Board for critical review of the draft manuscript.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="bibr1-0960327112456316">
<label>1</label>
<citation citation-type="book">
<collab collab-type="author">US Environmental Protection Agency</collab>. <source>The guidance for water utility response, recovery and remediation actions for man-made and/or technological emergencies. Office of Water (4601 M). EPA 810-R-02-001</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>US EPA</publisher-name>, <year>2002</year>.</citation>
</ref>
<ref id="bibr2-0960327112456316">
<label>2</label>
<citation citation-type="book">
<collab collab-type="author">US Environmental Protection Agency</collab>. <source>Large water system emergency response plan outline: guidance to assist community water systems in complying with the public health security and bioterrorism response act of 2002. EPA 810-F-03-007. Office of Water</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>US EPA</publisher-name>, <year>2003</year>.</citation>
</ref>
<ref id="bibr3-0960327112456316">
<label>3</label>
<citation citation-type="book">
<collab collab-type="author">Anonymous</collab>. <source>Rhine international warning and alert service. International Commission for the Protection of the Rhine Against Pollution</source>. <publisher-loc>Germany</publisher-loc>: <publisher-name>Kobler</publisher-name>, <year>1987</year>.</citation>
</ref>
<ref id="bibr4-0960327112456316">
<label>4</label>
<citation citation-type="web">
<collab collab-type="author">Bloomberg News</collab>. <article-title>Jilin cuts off water after chemical dumping accident, China Daily reports</article-title>. <comment>Available at:</comment> <ext-link ext-link-type="uri" xlink:href="http://www.bloomberg.com/news/2010-07-28">http://www.bloomberg.com/news/2010-07-28</ext-link><comment>(2010, accessed on September 2010)</comment>.</citation>
</ref>
<ref id="bibr5-0960327112456316">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khanna</surname>
<given-names>K</given-names>
</name>
</person-group>. <article-title>Inquiry questions long term effects on health of Camelford incident</article-title>. <source>Br Med J</source> <year>2005</year>; <volume>330</volume>: <fpage>275</fpage>.</citation>
</ref>
<ref id="bibr6-0960327112456316">
<label>6</label>
<citation citation-type="web">
<collab collab-type="author">Massachusetts Department of Environmental Protection (MassDEP).</collab> <source>Emergency response planning at public surface water sources. Water, wastewater and wetlands</source>. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.mass.gov/dep/water/drinking/erplan.htm">http://www.mass.gov/dep/water/drinking/erplan.htm</ext-link> <comment>(2009, accessed 9 August 2010)</comment>.</citation>
</ref>
<ref id="bibr7-0960327112456316">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hartong</surname>
<given-names>HJG</given-names>
</name>
</person-group>. <article-title>The Danube accident emergency warning system</article-title>. <source>Eur Water Pollut Control</source> <year>1994</year>; <volume>4</volume>: <fpage>41</fpage>–<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr8-0960327112456316">
<label>8</label>
<citation citation-type="journal">
<collab collab-type="author">Associated Press</collab>. <article-title>Acid accidentally put in town’s water supply</article-title>. <source>Cleveland Plain Dealer</source>, <issue>3 February</issue> <year>2009</year>.</citation>
</ref>
<ref id="bibr9-0960327112456316">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Powell</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Greenfield</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>RPH</given-names>
</name>
<etal/>
</person-group> <article-title>Assessment of toxic metal exposure following the Camelford water pollution incident: evidence of acute mobilization of lead into drinking water</article-title>. <source>Analyst</source> <year>1995</year>; <volume>120</volume>: <fpage>793</fpage>–<lpage>798</lpage>.</citation>
</ref>
<ref id="bibr10-0960327112456316">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>AQ</given-names>
</name>
</person-group>. <article-title>Emergency counterplan for drinking water pollution accident</article-title>. <source>Di Yi Jun Yi Da Xue Xue Bao</source> <year>2003</year>; <volume>23</volume>: <fpage>902</fpage>–<lpage>904</lpage>.</citation>
</ref>
<ref id="bibr11-0960327112456316">
<label>11</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Windholz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Budavari</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Stroumtsos</surname>
<given-names>LY</given-names>
</name>
<name>
<surname>Fertig</surname>
<given-names>MN</given-names>
</name>
</person-group> (eds) <source>The Merck index. An encyclopedia of chemicals and drugs</source>. <edition>9th ed</edition>. <publisher-loc>Rahway, New Jersey</publisher-loc>: <publisher-name>Merck &amp; Co.</publisher-name>, <year>1976</year>, pp. <fpage>7447</fpage>.</citation>
</ref>
<ref id="bibr12-0960327112456316">
<label>12</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Lide</surname>
<given-names>DR</given-names>
</name>
</person-group> (ed) <source>CRC handbook of chemistry and physics</source>. <edition>85th ed</edition>. <publisher-loc>Boca Raton, FL</publisher-loc>: <publisher-name>Chemical Rubber Publishing Co</publisher-name>, <year>2004–2005</year>.</citation>
</ref>
<ref id="bibr13-0960327112456316">
<label>13</label>
<citation citation-type="web">
<collab collab-type="author">International Programme on Chemical Safety (IPCS)</collab>. <article-title>Potassium permanganate</article-title>. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.inchem.org/documents/icsc/eics0672.htm">http://www.inchem.org/documents/icsc/eics0672.htm</ext-link> <comment>(2003, accessed on September 2010)</comment>.</citation>
</ref>
<ref id="bibr14-0960327112456316">
<label>14</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Eagleson</surname>
<given-names>M</given-names>
</name>
</person-group>. <source>Concise encyclopedia chemistry</source>. <publisher-loc>Berlin, Germany</publisher-loc>: <publisher-name>Walter de Gruyter</publisher-name>, <year>1994</year>, p. <fpage>622</fpage>.</citation>
</ref>
<ref id="bibr15-0960327112456316">
<label>15</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Reidies</surname>
<given-names>AH</given-names>
</name>
</person-group>. <article-title>Manganese and manganese alloys</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Mark</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Othmer</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Overberger</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Seaborg</surname>
<given-names>GT</given-names>
</name>
</person-group> (eds) <source>Kirk-Othmer encyclopedia of chemical technology</source>. <volume>Vol 14</volume>, <edition>3rd ed</edition>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>John Wiley &amp; Sons</publisher-name>, <year>1982</year>, pp. <fpage>824</fpage>–<lpage>895</lpage>.</citation>
</ref>
<ref id="bibr16-0960327112456316">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woolf</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Amarasiriwardena</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bellinger</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>A child with chronic manganese exposure from drinking water</article-title>. <source>Environ Health Perspect</source> <year>2002</year>; <volume>110</volume>: <fpage>613</fpage>–<lpage>616</lpage>.</citation>
</ref>
<ref id="bibr17-0960327112456316">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ritter</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Solomon</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sibley</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Sources, pathways, and relative risks of contaminants in surface water and groundwater: a perspective prepared for the walkerton inquiry</article-title>. <source>J Toxicol Environ Health A</source> <year>2002</year>; <volume>65</volume>: <fpage>1</fpage>–<lpage>142</lpage>.</citation>
</ref>
<ref id="bibr18-0960327112456316">
<label>18</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Schonwald</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Manganese</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Dart</surname>
<given-names>RC</given-names>
</name>
</person-group> (ed) <source>Medical toxicology</source>. <edition>3rd ed</edition>. <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Wolters Klower</publisher-name>, <year>2003</year>, pp. <fpage>1433</fpage>–<lpage>1436</lpage>.</citation>
</ref>
<ref id="bibr19-0960327112456316">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lalezary</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pirbazari</surname>
<given-names>M</given-names>
</name>
<name>
<surname>McGuire</surname>
<given-names>MJ</given-names>
</name>
</person-group>. <article-title>Oxidation of five earthy-musty taste and odor compounds</article-title>. <source>J Am Water Works Assoc</source> <year>1986</year>; <volume>78</volume>: <fpage>62</fpage>.</citation>
</ref>
<ref id="bibr20-0960327112456316">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devai</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Delaune</surname>
<given-names>RD</given-names>
</name>
</person-group>. <article-title>Effectiveness of selected chemicals for controlling emission of malodorous sulfur gases in sewage sludge</article-title>. <source>Environ Technol</source> <year>2002</year>; <volume>23</volume>: <fpage>319</fpage>–<lpage>329</lpage>.</citation>
</ref>
<ref id="bibr21-0960327112456316">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>FW</given-names>
</name>
</person-group>. <article-title>Characteristics and applications of controlled-release KMnO<sub>4</sub> for groundwater remediation</article-title>. <source>Chemosphere</source> <year>2007</year>; <volume>66</volume>: <fpage>2058</fpage>–<lpage>2066</lpage>.</citation>
</ref>
<ref id="bibr22-0960327112456316">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelson</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Al</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Cherry</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Loomer</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Geochemical reactions resulting from in situ oxidation of PCE-DNAPL by KMnO<sub>4</sub> in a sandy aquifer</article-title>. <source>Environ Sci Technol</source> <year>2001</year>; <volume>35</volume>: <fpage>1266</fpage>–<lpage>1275</lpage>.</citation>
</ref>
<ref id="bibr23-0960327112456316">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schnarr</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Truax</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Farquhar</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hood</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gonullu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Stickney</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Laboratory and controlled field experiments using potassium permanganate to remediate trichloroethylene and perchloroethylene DNAPLs in porous media</article-title>. <source>J Contam Hydrol</source> <year>1998</year>; <volume>29</volume>: <fpage>205</fpage>–<lpage>224</lpage>.</citation>
</ref>
<ref id="bibr24-0960327112456316">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schroth</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Oostrom</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wietsma</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Istok</surname>
<given-names>JD.</given-names>
</name>
</person-group> <article-title>In situ oxidation of trichloroethene by permanganate: effects on porous medium hydraulic properties</article-title>. <source>J Contam Hydrol</source> <year>2001</year>; <volume>50</volume>: <fpage>79</fpage>–<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr25-0960327112456316">
<label>25</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Duncan</surname>
<given-names>TO</given-names>
</name>
</person-group>. <source>The use of potassium permanganate in fisheries: A literature review</source>. <comment>PB-275397</comment>. <publisher-loc>Fayetteville, AR</publisher-loc>: <publisher-name>US Fisheries and Wildlife Service</publisher-name>, <year>1978</year>.</citation>
</ref>
<ref id="bibr26-0960327112456316">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tucker</surname>
<given-names>CS</given-names>
</name>
</person-group>. <article-title>Potassium permanganate demand of pond waters</article-title>. <source>Prog Fish Cult</source> <year>1984</year>; <volume>46</volume>: <fpage>24</fpage>–<lpage>28</lpage>.</citation>
</ref>
<ref id="bibr27-0960327112456316">
<label>27</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Bryant</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fulton</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Budd</surname>
<given-names>GC</given-names>
</name>
</person-group>. <source>Disinfection alternatives for safe drinking water</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Van Nostrand Reinhold</publisher-name>, <year>1992</year>.</citation>
</ref>
<ref id="bibr28-0960327112456316">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ficek</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Boll</surname>
<given-names>JE</given-names>
</name>
</person-group>. <article-title>Potassium permanganate: alternative to prechlorination</article-title>. <source>Aque</source> <year>1980</year>; <volume>7</volume>: <fpage>153</fpage>–<lpage>156</lpage>.</citation>
</ref>
<ref id="bibr29-0960327112456316">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Myers</surname>
<given-names>AG</given-names>
</name>
</person-group>. <article-title>Evaluating alternative disinfectants for THM control in small systems</article-title>. <source>J Am Water Works Assoc</source> <year>1990</year>; <volume>82</volume>: <fpage>77</fpage>–<lpage>84</lpage>.</citation>
</ref>
<ref id="bibr30-0960327112456316">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singer</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Borchardi</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Colthurst</surname>
<given-names>JM</given-names>
</name>
</person-group>. <article-title>The effects of permanganate treatment on trihalomethane formation in drinking water</article-title>. <source>J Am Water Works Assoc</source> <year>1980</year>; <volume>72</volume>: <fpage>573</fpage>–<lpage>578</lpage>.</citation>
</ref>
<ref id="bibr31-0960327112456316">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purcell</surname>
<given-names>FWF</given-names>
</name>
</person-group>. <article-title>Remarks on the treatment of acute gonorrheal urethritis in the male</article-title>. <source>Br J Venereal Dis</source> <year>1931</year>; <volume>7</volume>: <fpage>187</fpage>–<lpage>208</lpage>.</citation>
</ref>
<ref id="bibr32-0960327112456316">
<label>32</label>
<citation citation-type="journal">
<collab collab-type="author">Anonymous</collab>. <article-title>Rational treatment of urethritis</article-title>. <source>Mass Med J</source> <year>1906</year>; <volume>26</volume>: <fpage>454</fpage>–<lpage>455</lpage>.</citation>
</ref>
<ref id="bibr33-0960327112456316">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stalder</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Fleury</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sourisse</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Comparative effects of two topical antiseptics (chlorhexidine vs KMnO<sub>4</sub>) on bacterial flora in atopic dermatitis</article-title>. <source>Acta Derm Venereol Suppl (Stockh)</source> <year>1992</year>; <volume>176</volume>: <fpage>132</fpage>–<lpage>134</lpage>.</citation>
</ref>
<ref id="bibr34-0960327112456316">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>I</given-names>
</name>
</person-group>. <article-title>Should potassium permanganate be used in wound care?</article-title> <source>Nurs Times</source> <year>2003</year>; <volume>99</volume>(<issue>31</issue>): <fpage>61</fpage>.</citation>
</ref>
<ref id="bibr35-0960327112456316">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gelmetti</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Skin cleansing in children</article-title>. <source>J Eur Acad Dermatol Venereol</source> <year>2001</year>; <volume>15</volume>(<issue>Suppl 1</issue>):<fpage>12</fpage>–<lpage>15</lpage>.</citation>
</ref>
<ref id="bibr36-0960327112456316">
<label>36</label>
<citation citation-type="book">
<collab collab-type="author">Agency for Toxic Substances and Disease Registry</collab>. <source>Toxicological profile for manganese. Public Health Service</source>. <publisher-loc>Atlanta, GA</publisher-loc>: <publisher-name>US Department of Health and Human Services</publisher-name>, <year>2008</year>, pp. <fpage>490</fpage>.</citation>
</ref>
<ref id="bibr37-0960327112456316">
<label>37</label>
<citation citation-type="book">
<collab collab-type="author">National Research Council</collab>. <source>Manganese. Medical and biological effects of environmental pollutants. Division of Medical Sciences</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Academy Press</publisher-name>, <year>1973</year>, pp. <fpage>191</fpage>.</citation>
</ref>
<ref id="bibr38-0960327112456316">
<label>38</label>
<citation citation-type="book">
<collab collab-type="author">National Research Council</collab>. <source>Drinking water and health</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Academy Press</publisher-name>, <year>1977</year>, pp. <fpage>265</fpage>–<lpage>312</lpage>; <fpage>331</fpage>–<lpage>337</lpage>.</citation>
</ref>
<ref id="bibr39-0960327112456316">
<label>39</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Gosselin</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Hodge</surname>
<given-names>HC.</given-names>
</name>
</person-group> <source>Clinical toxicology of commercial products</source>. <edition>5th edition</edition>. <publisher-loc>Baltimore, MD</publisher-loc>: <publisher-name>Williams and Wilkins</publisher-name>, <year>1984</year>, pp. <fpage>II</fpage>–<lpage>109</lpage>.</citation>
</ref>
<ref id="bibr40-0960327112456316">
<label>40</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Temple</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>NA.</given-names>
</name>
</person-group> <article-title>Potassium permanganate. International Programme on Chemical Safety (Inchem)</article-title>. <comment>Poisons information monograph 409. Available at:</comment> <ext-link ext-link-type="uri" xlink:href="http://www.inchem.org/documents/pims/chemical/pim409.htm">http://www.inchem.org/documents/pims/chemical/pim409.htm</ext-link> <comment>(1998, accessed on September 2010)</comment>.</citation>
</ref>
<ref id="bibr41-0960327112456316">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dagali</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Golden</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Finkel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Austin</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Pyloric stenosis following ingestion of potassium permanganate</article-title>. <source>Am J Dig Dis</source> <year>1973</year>; <volume>18</volume>: <fpage>1091</fpage>–<lpage>1094</lpage>.</citation>
</ref>
<ref id="bibr42-0960327112456316">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhamrait</surname>
<given-names>RS</given-names>
</name>
</person-group>. <article-title>Airway obstruction following potassium permanganate ingestion</article-title>. <source>Anaesthesia</source> <year>2003</year>; <volume>58</volume>: <fpage>606</fpage>–<lpage>607</lpage>.</citation>
</ref>
<ref id="bibr43-0960327112456316">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hershkovitz</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Weizman</surname>
<given-names>Z</given-names>
</name>
</person-group>. <article-title>Potassium permanganate poisoning in infancy</article-title>. <source>Harefuah</source> <year>1991</year>; <volume>120</volume>: <fpage>512</fpage>–<lpage>513</lpage>.</citation>
</ref>
<ref id="bibr44-0960327112456316">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huntley</surname>
<given-names>AC</given-names>
</name>
</person-group>. <article-title>Oral ingestion of potassium permanganate or aluminum acetate in two patients</article-title>. <source>Arch Dermatol</source> <year>1984</year>; <volume>120</volume>: <fpage>1363</fpage>–<lpage>1365</lpage>.</citation>
</ref>
<ref id="bibr45-0960327112456316">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Middleton</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Jacyna</surname>
<given-names>M</given-names>
</name>
<name>
<surname>McClaren</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>HC</given-names>
</name>
</person-group>. <article-title>Haemorrhagic pancreatitis: a cause of death in severe potassium permanganate poisoning</article-title>. <source>Postgrad Med J</source> <year>1990</year>; <volume>66</volume>: <fpage>657</fpage>–<lpage>658</lpage>.</citation>
</ref>
<ref id="bibr46-0960327112456316">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Southwood</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lambe</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Ingestion of potassium permanganate crystals by a three-year-old boy</article-title>. <source>Med J Aust</source> <year>1987</year>; <volume>146</volume>: <fpage>639</fpage>–<lpage>640</lpage>.</citation>
</ref>
<ref id="bibr47-0960327112456316">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Choquart</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Frileux</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Gastric lesions caused by ingestion of potassium permanganate</article-title>. <source>Chirurgie</source> <year>1972</year>; <volume>98</volume>: <fpage>487</fpage>–<lpage>491</lpage>.</citation>
</ref>
<ref id="bibr48-0960327112456316">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Shannassy</surname>
<given-names>RM</given-names>
</name>
</person-group>. <article-title>Accidental ingestion of potassium permanganate</article-title>. <source>Med J Aust</source> <year>1987</year>; <volume>147</volume>: <fpage>420</fpage>.</citation>
</ref>
<ref id="bibr49-0960327112456316">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lifsshitz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shahak</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sofer</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Fatal potassium permanganate intoxication in an infant</article-title>. <source>J Toxicol Clin Toxicol</source> <year>1999</year>; <volume>37</volume>: <fpage>801</fpage>–<lpage>802</lpage>.</citation>
</ref>
<ref id="bibr50-0960327112456316">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>TB</given-names>
</name>
<name>
<surname>Cassidy</surname>
<given-names>DD</given-names>
</name>
</person-group>. <article-title>Unintentional ingestion of potassium permanganate</article-title>. <source>Pediatr Emerg Care</source> <year>2004</year>; <volume>20</volume>: <fpage>185</fpage>–<lpage>187</lpage>.</citation>
</ref>
<ref id="bibr51-0960327112456316">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kochhar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>SK</given-names>
</name>
</person-group>. <article-title>Potassium permanganate induced oesophageal stricture</article-title>. <source>Human Toxicol</source> <year>1986</year>; <volume>5</volume>: <fpage>393</fpage>–<lpage>394</lpage>.</citation>
</ref>
<ref id="bibr52-0960327112456316">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gawarammana</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Ariyananda</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Palangasinghe</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group> <article-title>Emerging epidemic of fatal human self-poisoning with a washing powder in Southern Sri Lanka: a prospective observational study</article-title>. <source>Clin Toxicol (Phila)</source> <year>2009</year>; <volume>47</volume>: <fpage>407</fpage>–<lpage>411</lpage>.</citation>
</ref>
<ref id="bibr53-0960327112456316">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacobziner</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Raybin</surname>
<given-names>HW</given-names>
</name>
</person-group>. <article-title>Potassium permanganate poisoning</article-title>. <source>Arch Pediatr</source> <year>1961</year>; <volume>78</volume>: <fpage>120</fpage>–<lpage>124</lpage>.</citation>
</ref>
<ref id="bibr54-0960327112456316">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Justus</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gastmeier</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Fatal potassium permanganate poisoning due to mistaking it for charcoal</article-title>. <source>Dtsch Gesundheitsw</source> <year>1967</year>; <volume>22</volume>: <fpage>897</fpage>–<lpage>899</lpage>.</citation>
</ref>
<ref id="bibr55-0960327112456316">
<label>55</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Olsen</surname>
<given-names>KR</given-names>
</name>
</person-group>. <source>Poisoning and drug overdose</source>. <edition>3rd ed</edition>. <publisher-loc>Norwalk, CT</publisher-loc>: <publisher-name>Appleton and Lange</publisher-name>, <year>1999</year>.</citation>
</ref>
<ref id="bibr56-0960327112456316">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willimott</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Freiman</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Potassium permanganate poisoning</article-title>. <source>Br Med J</source> <year>1936</year>; <volume>1</volume>: <fpage>58</fpage>–<lpage>59</lpage>.</citation>
</ref>
<ref id="bibr57-0960327112456316">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wisbauer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schmitt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mayatepek</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hoehn</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Akzidentelle kaliumpermanganatverätzung begleitet von schleimhaufnekrosen in ősophagus und magen</article-title>. <source>Monatsschr Kinderheilkd</source> <year>2008</year>; <volume>156</volume>(<issue>11</issue>): <fpage>1100</fpage>–<lpage>1103</lpage>.</citation>
</ref>
<ref id="bibr58-0960327112456316">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahomedy</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Mahomedy</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Canham</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Downing</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Jeal</surname>
<given-names>DE</given-names>
</name>
</person-group>. <article-title>Methemoblobinemia following treatment dispensed by witch doctors. Two cases of potassium permanganate poisoning</article-title>. <source>Anaesthesia</source> <year>1975</year>; <volume>30</volume>: <fpage>190</fpage>–<lpage>193</lpage>.</citation>
</ref>
<ref id="bibr59-0960327112456316">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ong</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>WL</given-names>
</name>
</person-group>. <article-title>Potassium permanganate poisoning: a rare cause of fatal self poisoning</article-title>. <source>J Accid Emerg Med</source> <year>1997</year>; <volume>14</volume>: <fpage>43</fpage>–<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr60-0960327112456316">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Critchley</surname>
<given-names>JAJH</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Freebairn</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Lolin</surname>
<given-names>YI</given-names>
</name>
</person-group>. <article-title>Fatal acute hepatorenal failure following potassium permanganate ingestion</article-title>. <source>Human Exp Toxicol</source> <year>1996</year>; <volume>15</volume>: <fpage>259</fpage>–<lpage>261</lpage>.</citation>
</ref>
<ref id="bibr61-0960327112456316">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lustig</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pitlik</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JB</given-names>
</name>
</person-group>. <article-title>Liver damage in acute self-induced hypermanganemia</article-title>. <source>Arch Intern Med</source> <year>1982</year>; <volume>142</volume>: <fpage>405</fpage>–<lpage>406</lpage>.</citation>
</ref>
<ref id="bibr62-0960327112456316">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raw</surname>
<given-names>N</given-names>
</name>
</person-group>. <article-title>Permanganate of potassium as an antidote for opium poisoning</article-title>. <source>Br Med J</source> <year>1895</year>; <volume>2</volume>(<issue>1802</issue>): <fpage>76</fpage>–<lpage>77</lpage>.</citation>
</ref>
<ref id="bibr63-0960327112456316">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luff</surname>
<given-names>AP</given-names>
</name>
</person-group>. <article-title>Permanganate of potassium as an antidote for opium and morphine poisoning</article-title>. <source>Br Med J</source> <year>1896</year>; <volume>1</volume>: <fpage>1193</fpage>–<lpage>1194</lpage>.</citation>
</ref>
<ref id="bibr64-0960327112456316">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maynard</surname>
<given-names>FP</given-names>
</name>
</person-group>. <article-title>The treatment of opium poisoning by permanganate of potassium</article-title>. <source>Br Med J</source> <year>1896</year>; <volume>1</volume>: <fpage>1194</fpage>–<lpage>1196</lpage>.</citation>
</ref>
<ref id="bibr65-0960327112456316">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Panchabhai</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Dangayach</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Krishnan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kothari</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Karnad</surname>
<given-names>DR</given-names>
</name>
</person-group>. <article-title>Oropharyngeal cleansing with 0.2% chlorhexidine for prevention of nosocomial pneumonia in critically ill patients: an open-label randomized trial with 0.01% potassium permanganate as control</article-title>. <source>Chest</source> <year>2009</year>; <volume>135</volume>(<issue>5</issue>): <fpage>1150</fpage>–<lpage>1156</lpage>.</citation>
</ref>
<ref id="bibr66-0960327112456316">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holzgraefe</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Poser</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Kijewski</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Beuche</surname>
<given-names>W</given-names>
</name>
</person-group>. <article-title>Chronic enteral poisoning caused by potassium permanganate: a case report</article-title>. <source>J Toxicol Clin Toxicol</source> <year>1986</year>; <volume>24</volume>: <fpage>235</fpage>–<lpage>244</lpage>.</citation>
</ref>
<ref id="bibr67-0960327112456316">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Degner</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bleich</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Riegel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sprung</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Poser</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Rüthe</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Follow-up study after enteral manganese poisoning: clinical, laboratory and neuroradiological findings</article-title>. <source>Nervenartz</source> <year>2000</year>; <volume>71</volume>: <fpage>416</fpage>–<lpage>419</lpage>.</citation>
</ref>
<ref id="bibr68-0960327112456316">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perl</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Olanow</surname>
<given-names>CW</given-names>
</name>
</person-group>. <article-title>The neuropathology of manganese-induced Parkinsonism</article-title>. <source>J Neuropathol Exp Neurol</source> <year>2007</year>; <volume>66</volume>: <fpage>675</fpage>–<lpage>682</lpage>.</citation>
</ref>
<ref id="bibr69-0960327112456316">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aschner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Guilarte</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>W</given-names>
</name>
</person-group>. <article-title>Manganese: recent advances in understanding its transport and neurotoxicity</article-title>. <source>Toxicol Appl Pharmacol</source> <year>2007</year>; <volume>221</volume>: <fpage>131</fpage>–<lpage>147</lpage>.</citation>
</ref>
<ref id="bibr70-0960327112456316">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newland</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Persistent effects of manganese on effortful responding and their relationship to manganese accumulation in the primate globus pallidus</article-title>. <source>Toxicol Appl Pharmacol</source> <year>1992</year>; <volume>113</volume>: <fpage>87</fpage>–<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr71-0960327112456316">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>CC</given-names>
</name>
</person-group>. <article-title>Parkinsonism induced by chronic manganese intoxication: an experience in Taiwan</article-title>. <source>Chang Gung Med J</source> <year>2007</year>; <volume>30</volume>: <fpage>385</fpage>–<lpage>395</lpage>.</citation>
</ref>
<ref id="bibr72-0960327112456316">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santamaria</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Salusky</surname>
<given-names>SI</given-names>
</name>
</person-group>. <article-title>Risk assessment of an essential element: manganese</article-title>. <source>J Toxicol Environ Health A</source> <year>2010</year>; <volume>73</volume>: <fpage>128</fpage>–<lpage>155</lpage>.</citation>
</ref>
<ref id="bibr73-0960327112456316">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Greger</surname>
<given-names>JL</given-names>
</name>
</person-group>. <article-title>Longitudinal changes of manganese-dependent superoxide dismutase and other indexes of manganese and iron status in women</article-title>. <source>Am J Clin Nutr</source> <year>1992</year>; <volume>55</volume>: <fpage>747</fpage>–<lpage>752</lpage>.</citation>
</ref>
<ref id="bibr74-0960327112456316">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finley</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>LK</given-names>
</name>
</person-group>. <article-title>Sex affects manganese absorption and retention by humans from a diet adequate in manganese</article-title>. <source>Am J Clin Nutr</source> <year>1994</year>; <volume>60</volume>: <fpage>949</fpage>–<lpage>955</lpage>.</citation>
</ref>
<ref id="bibr75-0960327112456316">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finley</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Penland</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Pettit</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>CD</given-names>
</name>
</person-group>. <article-title>Dietary manganese intake and type of lipid do not affect clinical or neurological measures in healthy young women</article-title>. <source>J Nutr</source> <year>2003</year>; <volume>133</volume>: <fpage>2849</fpage>–<lpage>2856</lpage>.</citation>
</ref>
<ref id="bibr76-0960327112456316">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawamura</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ikuta</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fukuzumi</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Intoxication by manganese in well water</article-title>. <source>Kitasato Arch Exp Med</source> <year>1941</year>; <volume>18</volume>: <fpage>145</fpage>–<lpage>169</lpage>.</citation>
</ref>
<ref id="bibr77-0960327112456316">
<label>77</label>
<citation citation-type="web">
<collab collab-type="author">US Environmental Protection Agency</collab>. <source>Drinking water health advisory for manganese</source>. <comment>EPA-822-R-04-003. Available at:</comment> <ext-link ext-link-type="uri" xlink:href="http://www.epa.gov/safewater/ccl/pdfs/reg_determine1/support_cc1_magnese_dwreport.pdf">http://www.epa.gov/safewater/ccl/pdfs/reg_determine1/support_cc1_magnese_dwreport.pdf</ext-link> <comment>(2004, accessed on September 2010)</comment>.</citation>
</ref>
<ref id="bibr78-0960327112456316">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kondakis</surname>
<given-names>XG</given-names>
</name>
<name>
<surname>Markis</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Leotsinidis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Prinou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Papapetropoulos</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Possible health effects of high manganese concentration in drinking water</article-title>. <source>Arch Environ Health</source> <year>1989</year>; <volume>44</volume>: <fpage>175</fpage>–<lpage>178</lpage>.</citation>
</ref>
<ref id="bibr79-0960327112456316">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vieregge</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Heinzow</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Korf</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Teichert</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Schleifenbaum</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mösinger</surname>
<given-names>HU</given-names>
</name>
</person-group>. <article-title>Long term exposure to manganese in rural well water has no neurological effects</article-title>. <source>Can J Neurol Sci</source> <year>1995</year>; <volume>22</volume>: <fpage>286</fpage>–<lpage>289</lpage>.</citation>
</ref>
<ref id="bibr80-0960327112456316">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwami</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Nakatsuka</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Motor neuron disease on the Kii Peninsula of Japan: excess manganese intake from food coupled with low magnesium in drinking water as a risk factor</article-title>. <source>Sci Total Environ</source> <year>1994</year>; <volume>149</volume>: <fpage>121</fpage>–<lpage>135</lpage>.</citation>
</ref>
<ref id="bibr81-0960327112456316">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouchard</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Laforest</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Vandelac</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bellinger</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mergler</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Hair manganese and hyperactive behaviors: pilot study of school-age children exposed through tap water</article-title>. <source>Environ Health Perspect</source> <year>2007</year>; <volume>115</volume>: <fpage>122</fpage>–<lpage>127</lpage>.</citation>
</ref>
<ref id="bibr82-0960327112456316">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouchard</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Sauvé</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Barbeau</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group> <article-title>Intellectual impairment in school-age children exposed to manganese from drinking water</article-title>. <source>Environ Health Perspect</source> <year>2011</year>; <volume>119</volume>: <fpage>138</fpage>–<lpage>143</lpage>.</citation>
</ref>
<ref id="bibr83-0960327112456316">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Copes</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Manganese in drinking water and intellectual impairment in school age children</article-title>. <source>Environ Health Perspect</source> <year>2011</year>; <volume>119</volume>: <fpage>A240</fpage>–<lpage>A241</lpage>.</citation>
</ref>
<ref id="bibr84-0960327112456316">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Factor-Litvak</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wasserman</surname>
<given-names>GA</given-names>
</name>
<etal/>
</person-group> <article-title>Manganese exposure from drinking water and children’s classroom behavior in Bangladesh</article-title>. <source>Environ Health Perspect</source> <year>2011</year>; <volume>119</volume>: <fpage>1501</fpage>–<lpage>1506</lpage>.</citation>
</ref>
<ref id="bibr85-0960327112456316">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wasserman</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<etal/>
</person-group> <article-title>Manganese exposure from drinking water and children’s academic achievement</article-title>. <source>Neurotoxicology</source> <year>2012</year>; <volume>33</volume>: <fpage>91</fpage>–<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr86-0960327112456316">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parvez</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wasserman</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Factor-Litvak</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group> <article-title>Arsenic exposure and motor function among children in Bangladesh</article-title>. <source>Environ Health Perspect</source> <year>2011</year>; <volume>119</volume>: <fpage>1665</fpage>–<lpage>1670</lpage>.</citation>
</ref>
<ref id="bibr87-0960327112456316">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sahni</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Leger</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Panaro</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group> <article-title>Case report: a metabolic disorder presenting as pediatric manganism</article-title>. <source>Environ Health Perspect</source> <year>2007</year>; <volume>115</volume>: <fpage>1776</fpage>–<lpage>1779</lpage>.</citation>
</ref>
<ref id="bibr88-0960327112456316">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group> <article-title>Effects of high-level manganese sewage irrigation on children’s neurobehavior</article-title>. <source>Chung Hua Yu Fang I Hsueh Tsa Chih</source> <year>1994</year>; <volume>28</volume>: <fpage>216</fpage>–<lpage>218</lpage> <comment>(as cited in ATSDR, 2008)</comment>.</citation>
</ref>
<ref id="bibr89-0960327112456316">
<label>89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wasserman</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Parvez</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group> <article-title>Water manganese exposure and children’s intellectual function in Araihazar, Bangladesh</article-title>. <source>Environ Health Perspect</source> <year>2006</year>; <volume>114</volume>: <fpage>124</fpage>–<lpage>129</lpage>.</citation>
</ref>
<ref id="bibr90-0960327112456316">
<label>90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>He</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Effect of manganese on learning abilities in school children</article-title>. <source>Chung Hua Yu Fang I Hsueh Tsa Chih</source> <year>1995</year>; <volume>29</volume>: <fpage>156</fpage>–<lpage>158</lpage>.</citation>
</ref>
<ref id="bibr91-0960327112456316">
<label>91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aschner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Erikson</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Dorman</surname>
<given-names>DC</given-names>
</name>
</person-group>. <article-title>Manganese dosimetry: species differences and implications for neurotoxicity</article-title>. <source>Crit Rev Toxicol</source> <year>2005</year>; <volume>35</volume>: <fpage>1</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr92-0960327112456316">
<label>92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gwiazda</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lucchini</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>D.</given-names>
</name>
</person-group> <article-title>Adequacy and consistency of animal studies to evaluate the neurotoxicity of chronic low-level manganese exposure in humans</article-title>. <source>J Toxicol Environ Health A</source> <year>2007</year>; <volume>70</volume>: <fpage>594</fpage>–<lpage>605</lpage>.</citation>
</ref>
<ref id="bibr93-0960327112456316">
<label>93</label>
<citation citation-type="web">
<collab collab-type="author">IPCS (International Programme on Chemical Safety)</collab>. <source>Manganese and its compounds</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name>. <comment>Available at:</comment> <ext-link ext-link-type="uri" xlink:href="http://www.inchem.org/documents/cicads/cicads/cicad12.htm">http://www.inchem.org/documents/cicads/cicads/cicad12.htm</ext-link> <comment>(1999, September 2010)</comment>.</citation>
</ref>
<ref id="bibr94-0960327112456316">
<label>94</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laitung</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Mercer</surname>
<given-names>DM.</given-names>
</name>
</person-group> <article-title>Manganese absorption through a burn. Burns, including thermal injuries</article-title>. <source>Burns Incl Therm Inj</source> <year>1983</year>; <volume>10</volume>: <fpage>145</fpage>–<lpage>146</lpage>.</citation>
</ref>
<ref id="bibr95-0960327112456316">
<label>95</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vago</surname>
<given-names>O</given-names>
</name>
</person-group>. <article-title>Toxic and caustic complications through use of so-called abortifacients</article-title>. <source>Z Geburtshilfe Perinatol</source> <year>1969</year>; <volume>170</volume>: <fpage>272</fpage>–<lpage>277</lpage>.</citation>
</ref>
<ref id="bibr96-0960327112456316">
<label>96</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verelli</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Osservazioni e considerazioni sull’applicazione di compresse di permanganate in vagina a scopo abortivo</article-title>. <source>Quaderni di Clinica Ostetrica e Ginecologica</source> <year>1965</year>; <volume>20</volume>: <fpage>617</fpage>–<lpage>643</lpage>.</citation>
</ref>
<ref id="bibr97-0960327112456316">
<label>97</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>LeCoz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mazerolles</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Delafargue</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Attempt at abortion with potassium permanganate tablets</article-title>. <source>Bull Fed Soc Gynecol Obster Langue Francaise</source> <year>1968</year>; <volume>20</volume>: <fpage>190</fpage>–<lpage>191</lpage>.</citation>
</ref>
<ref id="bibr98-0960327112456316">
<label>98</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aguilar Guerrero</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Repper Camacho</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Reyes Ceja</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>Considerations on 200 cases of vaginal burns by potassium permanganate</article-title>. <source>Ginecol Obstericia Mex</source> <year>1971</year>; <volume>29</volume>: <fpage>275</fpage>–<lpage>279</lpage>.</citation>
</ref>
<ref id="bibr99-0960327112456316">
<label>99</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aym</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bethemont</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Piana</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>Attempted abortions by potassium permanganate tablets</article-title>. <source>Bull Fed Soc Gynecol Obstet Lang Fr</source> <year>1964</year>; <volume>16</volume>: <fpage>299</fpage>–<lpage>303</lpage>.</citation>
</ref>
<ref id="bibr100-0960327112456316">
<label>100</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barber</surname>
<given-names>DT</given-names>
</name>
</person-group>. <article-title>Potassium permanganate as a cause of antepartum hemorrhage</article-title>. <source>J Obstet Gynaecol Br Commonw</source> <year>1961</year>; <volume>68</volume>: <fpage>680</fpage>–<lpage>681</lpage>.</citation>
</ref>
<ref id="bibr101-0960327112456316">
<label>101</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burt</surname>
<given-names>HE</given-names>
</name>
</person-group>. <article-title>Potassium permanganate necrosis of the vaginal wall</article-title>. <source>J Natl Med Assoc</source> <year>1961</year>; <volume>53</volume>: <fpage>261</fpage>–<lpage>262</lpage>.</citation>
</ref>
<ref id="bibr102-0960327112456316">
<label>102</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Baux</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Moreau</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>New cases of cervical dystocia caused by tablets of potassium permanganate</article-title>. <source>Bull Fed Soc Gynecol Obstet Lang Fr</source> <year>1955</year>; <volume>7</volume>: <fpage>591</fpage>–<lpage>593</lpage>.</citation>
</ref>
<ref id="bibr103-0960327112456316">
<label>103</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Funck-Brentano</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>The dangers of a false abortive agent: the tablet of potassium permanganate</article-title>. <source>Ann Med Leg Criminol Police Sci Toxicol</source> <year>1960</year>; <volume>40</volume>: <fpage>548</fpage>–<lpage>551</lpage>.</citation>
</ref>
<ref id="bibr104-0960327112456316">
<label>104</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hartemann</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dellestable</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Courtier</surname>
<given-names>V.</given-names>
</name>
</person-group> <article-title>Abortion attempts by potassium permanganate. Study on 107 cases observed in the clinique</article-title>. <source>Rev Fr Gynecol Obstet</source> <year>1965</year>; <volume>60</volume>: <fpage>755</fpage>–<lpage>774</lpage>.</citation>
</ref>
<ref id="bibr105-0960327112456316">
<label>105</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hartemann</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dellestable</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Courtier</surname>
<given-names>V</given-names>
</name>
</person-group>. <article-title>Prophylactic treatment of cervical and vaginal lesions following attempts at abortion with potassium permanganate</article-title>. <source>Bull Fed Soc Gynecol Obsete Lang Fr</source> <year>1964</year>; <volume>16</volume>: <fpage>605</fpage>–<lpage>606</lpage>.</citation>
</ref>
<ref id="bibr106-0960327112456316">
<label>106</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>JM</given-names>
</name>
</person-group>. <article-title>Potassium permanganate ulcers of the vagina</article-title>. <source>Obstet Gynecol</source> <year>1961</year>; <volume>18</volume>: <fpage>747</fpage>–<lpage>752</lpage>.</citation>
</ref>
<ref id="bibr107-0960327112456316">
<label>107</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obeng</surname>
<given-names>BB</given-names>
</name>
</person-group>. <article-title>The lay use of potassium permanganate as an abortifacient</article-title>. <source>Br J Clin Pract</source> <year>1968</year>; <volume>22</volume>: <fpage>465</fpage>–<lpage>469</lpage>.</citation>
</ref>
<ref id="bibr108-0960327112456316">
<label>108</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sachs</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>Shamoun</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Chemical burns of the female genitalia after use of potassium permanganate</article-title>. <source>Zentralbl Gynakol</source> <year>1961</year>; <volume>83</volume>: <fpage>459</fpage>–<lpage>463</lpage>.</citation>
</ref>
<ref id="bibr109-0960327112456316">
<label>109</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soymie</surname>
<given-names>JC</given-names>
</name>
</person-group>. <article-title>The danger of intravaginal potassium permanganate tablets used wrongly as an agent in criminal abortion</article-title>. <source>Gaz Med Fr</source> <year>1960</year>; <volume>67</volume>: <fpage>481</fpage>–<lpage>484</lpage>.</citation>
</ref>
<ref id="bibr110-0960327112456316">
<label>110</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vandergriff</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Diddle</surname>
<given-names>AW</given-names>
</name>
</person-group>. <article-title>Intravaginal use of potassium permanganate as an abortifacient: an error in diagnosis</article-title>. <source>Obstet Gynecol</source> <year>1966</year>; <volume>28</volume>: <fpage>155</fpage>–<lpage>157</lpage>.</citation>
</ref>
<ref id="bibr111-0960327112456316">
<label>111</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Webster</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Steward</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Potassium permanganate burns of the vagina</article-title>. <source>Q Bull Northwest Univ Med Sch</source> <year>1957</year>; <volume>31</volume>: <fpage>329</fpage>–<lpage>332</lpage>.</citation>
</ref>
<ref id="bibr112-0960327112456316">
<label>112</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jetter</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Hunter</surname>
<given-names>FT</given-names>
</name>
</person-group>. <article-title>Death from attempted abortion with a potassium permanganate douche</article-title>. <source>N Engl J Med</source> <year>1949</year>; <volume>240</volume>: <fpage>794</fpage>–<lpage>798</lpage>.</citation>
</ref>
<ref id="bibr113-0960327112456316">
<label>113</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baron</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Moss</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Caustic burn caused by potassium permanganate</article-title>. <source>Arch Dis Child</source> <year>2003</year>; <volume>88</volume>: <fpage>96</fpage>.</citation>
</ref>
<ref id="bibr114-0960327112456316">
<label>114</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michaels</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Zugsmith</surname>
<given-names>GS</given-names>
</name>
</person-group>. <article-title>Potassium permanganate burn of the eye</article-title>. <source>Eye Ear Nose and Throat Monthly</source> <year>1973</year>; <volume>52</volume>: <fpage>42</fpage>–<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr115-0960327112456316">
<label>115</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sigg</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Leikin</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Sigg</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mullin</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Treatment of ocular potassium permanganate exposure with 5% ascorbic acid solution</article-title>. <source>Ann Emerg Med</source> <year>1998</year>; <volume>32</volume>: <fpage>754</fpage>–<lpage>755</lpage>.</citation>
</ref>
<ref id="bibr116-0960327112456316">
<label>116</label>
<citation citation-type="web">
<collab collab-type="author">US Environmental Protection Agency (US EPA)</collab>. <source>Health effects support document for manganese</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>Office of Water (4304T) Health and Ecological Criteria Division</publisher-name>. <comment>EPA 822-R-03-003. Available at:</comment> <ext-link ext-link-type="uri" xlink:href="www.epa.gov/safewater/ccl/pdf/manganese.pdf">www.epa.gov/safewater/ccl/pdf/manganese.pdf</ext-link> <comment>(2003, September 2010)</comment>.</citation>
</ref>
<ref id="bibr117-0960327112456316">
<label>117</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burton</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Guilarte</surname>
<given-names>TR</given-names>
</name>
</person-group>. <article-title>Manganese neurotoxicity: lessons learned from longitudinal studies in nonhuman primates</article-title>. <source>Environ Health Perspect</source> <year>2009</year>; <volume>117</volume>: <fpage>325</fpage>–<lpage>332</lpage>.</citation>
</ref>
<ref id="bibr118-0960327112456316">
<label>118</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smyth</surname>
<given-names>HF </given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Carpenter</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Weil</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Pozzani</surname>
<given-names>UC</given-names>
</name>
<name>
<surname>Striegel</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Nycum</surname>
<given-names>JS</given-names>
</name>
</person-group>. <article-title>Range-finding toxicity data: list VII</article-title>. <source>Am Ind Hyg Assoc J</source> <year>1969</year>; <volume>30</volume>: <fpage>470</fpage>–<lpage>476</lpage>.</citation>
</ref>
<ref id="bibr119-0960327112456316">
<label>119</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saganuwan</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Ahur</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Yohanna</surname>
<given-names>CA</given-names>
</name>
</person-group>. <article-title>Acute toxicity studies of potassium permanganate in Swiss albino mice</article-title>. <source>Niger J Physiol Sci</source> <year>2008</year>; <volume>23</volume>: <fpage>31</fpage>–<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr120-0960327112456316">
<label>120</label>
<citation citation-type="book">
<collab collab-type="author">European Chemicals Bureau</collab>. <source>IUCLID dataset. Potassium permanganate. Substance ID 7722-64-7</source>. <publisher-loc>Luxembourg, Germany</publisher-loc> <publisher-name>European Commission</publisher-name>, <year>2000</year>, pp. <fpage>62</fpage>.</citation>
</ref>
<ref id="bibr121-0960327112456316">
<label>121</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joardar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Comparisons of clastogenicity of inorganic Mn administered in cationic and anionic forms in vivo</article-title>. <source>Mutat Res</source> <year>1990</year>; <volume>240</volume>: <fpage>159</fpage>–<lpage>163</lpage>.</citation>
</ref>
<ref id="bibr122-0960327112456316">
<label>122</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holbrook</surname>
<given-names>DJ </given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Washington</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Leake,</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>Brubaker</surname>
<given-names>PE</given-names>
</name>
</person-group>. <article-title>Studies on the evaluation of the toxicity of various salts of lead, manganese, platinum, and palladium</article-title>. <source>Environ Health Perspect</source> <year>1975</year>; <volume>10</volume>: <fpage>95</fpage>–<lpage>101</lpage>.</citation>
</ref>
<ref id="bibr123-0960327112456316">
<label>123</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kostial</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kello</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jugo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rabar</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Maljković</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Influence of age on metal metabolism and toxicity</article-title>. <source>Environ Health Perspect</source> <year>1978</year>; <volume>25</volume>: <fpage>81</fpage>–<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr124-0960327112456316">
<label>124</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehnberg</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Hein</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Lasky</surname>
<given-names>JW</given-names>
</name>
</person-group>. <article-title>Chronic manganese oxide administration to pre-weanling rats: manganese accumulation and distribution</article-title>. <source>J Toxicol Environ Health</source> <year>1980</year>; <volume>6</volume>: <fpage>217</fpage>–<lpage>226</lpage>.</citation>
</ref>
<ref id="bibr125-0960327112456316">
<label>125</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Junnarkar</surname>
<given-names>AY</given-names>
</name>
</person-group>. <article-title>Behavioural and toxic profile of some essential trace metal salts in mice and rats</article-title>. <source>Ind J Pharmacol</source> <year>1991</year>; <volume>23</volume>: <fpage>153</fpage>–<lpage>159</lpage>.</citation>
</ref>
<ref id="bibr126-0960327112456316">
<label>126</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kojima</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hirai</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kiyozumi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sasawa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>OT</given-names>
</name>
</person-group>. <article-title>Studies on poisonous metals. X. Metabolic fate of manganese after oral administration of excessive manganese chloride in rats</article-title>. <source>Chem Pharm Bull</source> <year>1983</year>; <volume>31</volume>: <fpage>2459</fpage>–<lpage>2465</lpage>.</citation>
</ref>
<ref id="bibr127-0960327112456316">
<label>127</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lipe</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Duhart</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Newport</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Slikker</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>SF</given-names>
</name>
</person-group>. <article-title>Effect of manganese on the concentration of amino acids in different regions of the rat brain</article-title>. <source>J Environ Sci Health</source> <year>1999</year>; <volume>B34</volume>(<issue>1</issue>): <fpage>119</fpage>–<lpage>132</lpage>.</citation>
</ref>
<ref id="bibr128-0960327112456316">
<label>128</label>
<citation citation-type="book">
<collab collab-type="author">National Toxicology Program</collab>. <source>Toxicology and carcinogenesis studies of manganese (II) sulfate monohydrate in F344/N rats and B6C3F1 mice (feed study)</source>. <comment>Technical Report Series No. 428</comment>. <publisher-loc>NC</publisher-loc>: <publisher-name>Research Triangle Park, Public Health Service</publisher-name>, <year>1993</year>.</citation>
</ref>
<ref id="bibr129-0960327112456316">
<label>129</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gianutsos</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>MT</given-names>
</name>
</person-group>. <article-title>Alterations in brain dopamine and GABA following inorganic or organic manganese administration</article-title>. <source>Neurotoxicology</source> <year>1982</year>; <volume>3</volume>: <fpage>75</fpage>–<lpage>81</lpage>.</citation>
</ref>
<ref id="bibr130-0960327112456316">
<label>130</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ikarashi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tsuchiya</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Detection of contact sensitivity of metal salts using the murine local lymph node assay</article-title>. <source>Toxicol Lett</source> <year>1992</year>; <volume>62</volume>: <fpage>53</fpage>–<lpage>61</lpage>.</citation>
</ref>
<ref id="bibr131-0960327112456316">
<label>131</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shukla</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Chandra</surname>
<given-names>SV</given-names>
</name>
</person-group>. <article-title>Striatal dopamine turnover and L-dopa treatment after short-term exposure of rats to manganese</article-title>. <source>Arch Toxicol</source> <year>1981</year>; <volume>47</volume>: <fpage>191</fpage>–<lpage>196</lpage>.</citation>
</ref>
<ref id="bibr132-0960327112456316">
<label>132</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chandra</surname>
<given-names>SV</given-names>
</name>
</person-group>. <article-title>Psychiatric illness due to manganese poisoning</article-title>. <source>Acta Psychiat Scand</source> <year>1983</year>; <volume>67</volume> (<issue>Suppl. 303</issue>): <fpage>49</fpage>–<lpage>54</lpage>.</citation>
</ref>
<ref id="bibr133-0960327112456316">
<label>133</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subhash</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Padmashree</surname>
<given-names>TS</given-names>
</name>
</person-group>. <article-title>Regional distribution of dopamine β-hydroxylase and monoamine oxidase in the brains of rats exposed to manganese</article-title>. <source>Food Chem Toxicol</source> <year>1990</year>; <volume>28</volume>: <fpage>567</fpage>–<lpage>570</lpage>.</citation>
</ref>
<ref id="bibr134-0960327112456316">
<label>134</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montes</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Alcaraz-Zubeldia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Muriel</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rios</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Striatal manganese accumulation induces changes in dopamine metabolism in the cirrhotic rat</article-title>. <source>Brain Res</source> <year>2001</year>; <volume>891</volume>: <fpage>123</fpage>–<lpage>129</lpage>.</citation>
</ref>
<ref id="bibr135-0960327112456316">
<label>135</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leung</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>The effects of chronic manganese feeding on the activity of monoamine oxidase in various organs of the developing rat</article-title>. <source>Comp Biochem Physiol</source> <year>1982</year>; <volume>71C</volume>(<issue>2</issue>): <fpage>223</fpage>–<lpage>228</lpage>.</citation>
</ref>
<ref id="bibr136-0960327112456316">
<label>136</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonilla</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Increased GABA content in caudate nucleus of rats after chronic manganese chloride administration</article-title>. <source>J Neurochem</source> <year>1978</year>; <volume>31</volume>: <fpage>551</fpage>–<lpage>552</lpage>.</citation>
</ref>
<ref id="bibr137-0960327112456316">
<label>137</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calabresi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ammassari-Teule</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gubellini</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group> <article-title>A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication</article-title>. <source>Neurobiol Dis</source> <year>2001</year>; <volume>8</volume>: <fpage>419</fpage>–<lpage>432</lpage>.</citation>
</ref>
<ref id="bibr138-0960327112456316">
<label>138</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spadoni</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Stefani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Morello</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lavaroni</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Giacomini</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sancesario</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Selective vulnerability of pallidal neurons in the early phases of manganese intoxication</article-title>. <source>Exp Brain Res</source> <year>2000</year>; <volume>135</volume>: <fpage>544</fpage>–<lpage>551</lpage>.</citation>
</ref>
<ref id="bibr139-0960327112456316">
<label>139</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonilla</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Chronic manganese intake induces changes in the motor activity of rats</article-title>. <source>Exp Neurol</source> <year>1984</year>; <volume>84</volume>: <fpage>696</fpage>–<lpage>700</lpage>.</citation>
</ref>
<ref id="bibr140-0960327112456316">
<label>140</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonilla</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>ALN</given-names>
</name>
</person-group>. <article-title>Effects of chronic manganese intake on the levels of biogenic amines in rat brain regions</article-title>. <source>Neurobehav Toxicol Teratol</source> <year>1984</year>; <volume>6</volume>: <fpage>341</fpage>–<lpage>344</lpage>.</citation>
</ref>
<ref id="bibr141-0960327112456316">
<label>141</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bull</surname>
<given-names>RJ</given-names>
</name>
</person-group>. <article-title>Paradoxical decrease in corpus striatal manganese concentrations with manganese load</article-title>. <source>Commun Psychopharmacol</source> <year>1978</year>; <volume>2</volume>: <fpage>17</fpage>–<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr142-0960327112456316">
<label>142</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nachtman</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Tubben</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Commissaris</surname>
<given-names>RL</given-names>
</name>
</person-group>. <article-title>Behavioral effects of chronic manganese administration in rats: locomotor activity studies</article-title>. <source>Neurobehav Toxicol Teratol</source> <year>1986</year>; <volume>8</volume>: <fpage>711</fpage>–<lpage>715</lpage>.</citation>
</ref>
<ref id="bibr143-0960327112456316">
<label>143</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eriksson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lenngren</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Heilbronn</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Effect of long-term administration of manganese on biogenic amine levels in discrete striatal regions of rat brain</article-title>. <source>Arch Toxicol</source> <year>1987</year>; <volume>59</volume>: <fpage>426</fpage>–<lpage>431</lpage>.</citation>
</ref>
<ref id="bibr144-0960327112456316">
<label>144</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Komura</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sakamoto</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Effects of manganese forms on biogenic amines in the brain and behavioral alterations in the mouse: long-term-oral administration of several manganese compounds</article-title>. <source>Environ Res</source> <year>1992</year>; <volume>57</volume>: <fpage>34</fpage>–<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr145-0960327112456316">
<label>145</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boyes</surname>
<given-names>WK</given-names>
</name>
</person-group>. <article-title>Essentiality, toxicity and uncertainty in the risk assessment of manganese</article-title>. <source>J Toxicol Environ Health A</source> <year>2010</year>; <volume>73</volume>: <fpage>159</fpage>–<lpage>165</lpage>.</citation>
</ref>
<ref id="bibr146-0960327112456316">
<label>146</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hurley</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Asling</surname>
<given-names>CW</given-names>
</name>
</person-group>. <article-title>Localized epiphyseal dysplasia in offspring of manganese-deficient rats</article-title>. <source>Anat Rec</source> <year>1963</year>; <volume>145</volume>: <fpage>25</fpage>–<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr147-0960327112456316">
<label>147</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shils</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>McCollum</surname>
<given-names>EV</given-names>
</name>
</person-group>. <article-title>Further studies on the symptoms of manganese deficiency in the rat and mouse</article-title>. <source>J Nutr</source> <year>1943</year>; <volume>26</volume>: <fpage>1</fpage>–<lpage>19</lpage>.</citation>
</ref>
<ref id="bibr148-0960327112456316">
<label>148</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erway</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hurley</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>AS</given-names>
</name>
</person-group>. <article-title>Congenital ataxia and otolith defects due to manganese deficiency in mice</article-title>. <source>J Nutr</source> <year>1970</year>; <volume>100</volume>: <fpage>643</fpage>–<lpage>654</lpage>.</citation>
</ref>
<ref id="bibr149-0960327112456316">
<label>149</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shrader</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Everson</surname>
<given-names>GJ</given-names>
</name>
</person-group>. <article-title>Anomalous development of otoliths associated with postural defects in manganese-deficient guinea pigs</article-title>. <source>J Nutr</source> <year>1967</year>; <volume>91</volume>: <fpage>453</fpage>–<lpage>460</lpage>.</citation>
</ref>
<ref id="bibr150-0960327112456316">
<label>150</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tholin</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Palm</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hallmans</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sandstrom</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Manganese status during pregnancy</article-title>. <source>Ann NY Acad Sci</source> <year>1993</year>; <volume>678</volume>: <fpage>379</fpage>–<lpage>380</lpage>.</citation>
</ref>
<ref id="bibr151-0960327112456316">
<label>151</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dorman</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Struve</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Vitarella</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Byerly</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Goetz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Neurotoxicity of manganese chloride in neonatal and adult CD rats following subchronic (21-day) high-dose oral exposures</article-title>. <source>J Appl Toxicol</source> <year>2000</year>; <volume>20</volume>: <fpage>179</fpage>–<lpage>187</lpage>.</citation>
</ref>
<ref id="bibr152-0960327112456316">
<label>152</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehnberg</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Hein</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Linko</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Laskey</surname>
<given-names>JW</given-names>
</name>
</person-group>. <article-title>Chronic ingestion of Mn<sub>3</sub>O<sub>4</sub> by rats: tissue accumulation and distribution of manganese in two generations</article-title>. <source>J Toxicol Environ Health</source> <year>1982</year>; <volume>9</volume>: <fpage>175</fpage>–<lpage>188</lpage>.</citation>
</ref>
<ref id="bibr153-0960327112456316">
<label>153</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carter</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Hein</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Rehnberg</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Laskey</surname>
<given-names>JW</given-names>
</name>
</person-group>. <article-title>Chronic manganese oxide ingestion in rats: Hematological effects</article-title>. <source>J Toxicol Environ Health</source> <year>1980</year>; <volume>6</volume>: <fpage>207</fpage>–<lpage>216</lpage>.</citation>
</ref>
<ref id="bibr154-0960327112456316">
<label>154</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guilarte</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>McGlothan</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Degaonkar</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: A <sup>1</sup>H-MRS and MRI study</article-title>. <source>Toxicol Sci</source> <year>2006</year>; <volume>94</volume>: <fpage>351</fpage>–<lpage>358</lpage>.</citation>
</ref>
<ref id="bibr155-0960327112456316">
<label>155</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Golub</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Hogrefe</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Germann</surname>
<given-names>SL</given-names>
</name>
<etal/>
</person-group> <article-title>Neurobehavioral evaluation of rhesus monkey infants fed cow’s milk formula, soy formula or soy formula with added manganese</article-title>. <source>Neurotoxicol Teratol</source> <year>2005</year>; <volume>27</volume>: <fpage>615</fpage>–<lpage>627</lpage>.</citation>
</ref>
<ref id="bibr156-0960327112456316">
<label>156</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Murthy</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Chandra</surname>
<given-names>SV</given-names>
</name>
</person-group>. <article-title>Neuromelanin in manganese-exposed primates</article-title>. <source>Toxicol Lett</source> <year>1980</year>; <volume>6</volume>: <fpage>17</fpage>–<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr157-0960327112456316">
<label>157</label>
<citation citation-type="book">
<collab collab-type="author">World Health Organization (WHO)</collab>. <source>Manganese in drinking water. Background document for development of WHO guidelines for drinking-water quality</source>. <comment>WHO/SDE/WSH/03.04/104</comment>. <publisher-loc>Lyon, France</publisher-loc>: <publisher-name>World Health Organization</publisher-name>, <year>2004</year>.</citation>
</ref>
<ref id="bibr158-0960327112456316">
<label>158</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teeguarden</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Dorman</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Covington</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Clewell</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>ME</given-names>
</name>
</person-group>. <article-title>Pharmacokinetic modeling of manganese. I. Dose dependencies of uptake and elimination</article-title>. <source>J Toxicol Environ Health A</source> <year>2007</year>; <volume>70</volume>: <fpage>1493</fpage>–<lpage>1504</lpage>.</citation>
</ref>
<ref id="bibr159-0960327112456316">
<label>159</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teeguarden</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Dorman</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Nong</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Covington</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Clewell</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>ME</given-names>
</name>
</person-group>. <article-title>Pharmacokinetic modeling of manganese. II. Hepatic processing after ingestion and inhalation</article-title>. <source>J Toxicol Environ Health A</source> <year>2007</year>; <volume>70</volume>: <fpage>1505</fpage>–<lpage>1514</lpage>.</citation>
</ref>
<ref id="bibr160-0960327112456316">
<label>160</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teeguarden</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Gearhart</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Clewell</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Covington</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Nong</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>ME</given-names>
</name>
</person-group>. <article-title>Pharmacokinetic modeling of manganese. III. Physiological approaches accounting for background and tracer kinetics</article-title>. <source>J Toxicol Environ Health A</source> <year>2007</year>; <volume>70</volume>: <fpage>1515</fpage>–<lpage>1526</lpage>.</citation>
</ref>
<ref id="bibr161-0960327112456316">
<label>161</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Assem</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>LS.</given-names>
</name>
</person-group> <article-title>The mutagenicity and carcinogenicity evidence of inorganic manganese compounds: a synthesis of the evidence</article-title>. <source>J Toxicol Environ Health B</source> <year>2011</year>; <volume>14</volume>: <fpage>537</fpage>–<lpage>570</lpage>
</citation>
</ref>
<ref id="bibr162-0960327112456316">
<label>162</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Umeda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Inducibility of chromosomal aberrations by metal compounds in cultured mammalian cells</article-title>. <source>Mutat Res</source> <year>1979</year>; <volume>67</volume>: <fpage>221</fpage>–<lpage>229</lpage>.</citation>
</ref>
<ref id="bibr163-0960327112456316">
<label>163</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsuda</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>K</given-names>
</name>
</person-group>. <article-title>Chromosomal aberrations and morphological transformation in hamster embryonic cells treated with potassium dichromate <italic>in vitro</italic>
</article-title>. <source>Mutat Res</source> <year>1977</year>; <volume>46</volume>: <fpage>87</fpage>–<lpage>94</lpage>.</citation>
</ref>
<ref id="bibr164-0960327112456316">
<label>164</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Maynard</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Loosli</surname>
<given-names>JK</given-names>
</name>
</person-group>. <source>Animal nutrition</source>. <edition>6th ed</edition>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>McGraw-Hill</publisher-name>, <year>1969</year>, pp. <fpage>204</fpage>–<lpage>207</lpage>.</citation>
</ref>
<ref id="bibr165-0960327112456316">
<label>165</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tobia</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>The management of potassium permanganate ocular burn</article-title>. <source>Bull Ophthalmol Soc Egypt</source> <year>1976</year>; <volume>69</volume>: <fpage>645</fpage>–<lpage>646</lpage>.</citation>
</ref>
<ref id="bibr166-0960327112456316">
<label>166</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santos-Burgoa</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rios</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mercado</surname>
<given-names>LA</given-names>
</name>
<etal/>
</person-group> <article-title>Exposure to manganese: health effects on the general population, a pilot study in central Mexico</article-title>. <source>Environ Res</source> <year>2001</year>; <volume>85</volume>: <fpage>90</fpage>–<lpage>104</lpage>.</citation>
</ref>
<ref id="bibr167-0960327112456316">
<label>167</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Milatovic</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>RC</given-names>
</name>
<etal/>
</person-group> <article-title>Manganese induces oxidative impairment in cultured rat astrocytes</article-title>. <source>Toxicol Sci</source> <year>2007</year>; <volume>98</volume>: <fpage>198</fpage>–<lpage>205</lpage>.</citation>
</ref>
<ref id="bibr168-0960327112456316">
<label>168</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Anantharam</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Saetveit</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Houk</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Kanthasamy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kanthasamy</surname>
<given-names>AG</given-names>
</name>
</person-group>. <article-title>Normal cellular prion protein protects against manganese-induced oxidative stress and apoptotic cell death</article-title>. <source>Toxicol Sci</source> <year>2007</year>; <volume>98</volume>: <fpage>495</fpage>–<lpage>509</lpage>.</citation>
</ref>
<ref id="bibr169-0960327112456316">
<label>169</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schneider</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Decamp</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bouquio</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Syversen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Guilarte</surname>
<given-names>TR</given-names>
</name>
</person-group>. <article-title>Effects of chronic manganese exposure on working memory in non-human primates</article-title>. <source>Brain Res</source> <year>2009</year>; <volume>1258</volume>: <fpage>86</fpage>–<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr170-0960327112456316">
<label>170</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elsner</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Spangler</surname>
<given-names>JG</given-names>
</name>
</person-group>. <article-title>Neurotoxicity of inhaled manganese: public health danger in the shower</article-title>. <source>Med Hypotheses</source> <year>2005</year>; <volume>65</volume>: <fpage>607</fpage>–<lpage>616</lpage>.</citation>
</ref>
<ref id="bibr171-0960327112456316">
<label>171</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aschner</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Manganese in the shower: mere speculation over an invalidated public health danger</article-title>. <source>Med Hypotheses</source> <year>2006</year>; <volume>66</volume>: <fpage>200</fpage>–<lpage>201</lpage>.</citation>
</ref>
<ref id="bibr172-0960327112456316">
<label>172</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krieger</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Krieger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Janssen</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Grass</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Theilmann</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lichtnecker</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Manganese and chronic encephalopathy</article-title>. <source>Lancet</source> <year>1995</year>; <volume>346</volume>: <fpage>270</fpage>–<lpage>274</lpage>.</citation>
</ref>
<ref id="bibr173-0960327112456316">
<label>173</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pomier-Layrargues</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Spahr</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Butterworth</surname>
<given-names>RF</given-names>
</name>
</person-group>. <article-title>Increased manganese concentration in pallidum of cirrhotic patients</article-title>. <source>Lancet</source> <year>1995</year>; <volume>345</volume>: <fpage>735</fpage>.</citation>
</ref>
<ref id="bibr174-0960327112456316">
<label>174</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rose</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Butterworth</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Zayed</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction</article-title>. <source>Gastroenterology</source> <year>1999</year>; <volume>117</volume>: <fpage>640</fpage>–<lpage>644</lpage>.</citation>
</ref>
<ref id="bibr175-0960327112456316">
<label>175</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spahr</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Butterworth</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Fontaine</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Increased blood manganese in cirrhotic patients: relationships to pallidal magnetic resonance signal hyperintensity and neurological symptoms</article-title>. <source>Hepatology</source> <year>1996</year>; <volume>24</volume>: <fpage>1116</fpage>–<lpage>1120</lpage>.</citation>
</ref>
<ref id="bibr176-0960327112456316">
<label>176</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loranger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zayed</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Environmental and occupational exposure to manganese: a multimedia assessment</article-title>. <source>Int Arch Occup Environ Health</source> <year>1995</year>; <volume>67</volume>: <fpage>101</fpage>–<lpage>110</lpage>.</citation>
</ref>
<ref id="bibr177-0960327112456316">
<label>177</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Harvey</surname>
<given-names>SC</given-names>
</name>
</person-group>. <article-title>Antiseptics and disinfectants; fungicides; ectoparasiticides</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Goodman</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Gilman</surname>
<given-names>A</given-names>
</name>
</person-group> (eds) <source>The pharmacological basis of therapeutics</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Macmillan</publisher-name>, <year>1975</year>, pp. <fpage>998</fpage>.</citation>
</ref>
<ref id="bibr178-0960327112456316">
<label>178</label>
<citation citation-type="book">
<collab collab-type="author">Food and Nutrition Board. National Research Council</collab>. <source>Recommeded dietary allowances</source>. <edition>10th ed</edition>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Academy Press</publisher-name>, <year>1989</year>.</citation>
</ref>
<ref id="bibr179-0960327112456316">
<label>179</label>
<citation citation-type="book">
<collab collab-type="author">Food and Nutrition Board. Institute of Medicine</collab>. <source>Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, molybdenum, nickel, silicon, vanadium and zinc</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Academies Press</publisher-name>, <year>2001</year>.</citation>
</ref>
<ref id="bibr180-0960327112456316">
<label>180</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pennington</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>BE</given-names>
</name>
</person-group>. <article-title>Total diet study nutritional elements, 1982-1989</article-title>. <source>J Am Diet Assoc</source> <year>1991</year>; <volume>91</volume>: <fpage>179</fpage>–<lpage>183</lpage>.</citation>
</ref>
<ref id="bibr181-0960327112456316">
<label>181</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barceloux</surname>
<given-names>DG</given-names>
</name>
</person-group>. <article-title>Manganese</article-title>. <source>J Toxicol Clin Toxicol</source> <year>1999</year>; <volume>37</volume>: <fpage>293</fpage>–<lpage>307</lpage>.</citation>
</ref>
<ref id="bibr182-0960327112456316">
<label>182</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hurley</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Chambers</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Screening procedures for eye irritation</article-title>. <source>Food Chem Toxicol</source> <year>1993</year>; <volume>31</volume>: <fpage>87</fpage>–<lpage>94</lpage>.</citation>
</ref>
<ref id="bibr183-0960327112456316">
<label>183</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedenwald</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>WF</given-names>
</name>
<name>
<surname>Herrmann</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Acid-base tolerance of the cornea</article-title>. <source>Arch Ophthalmol</source> <year>1944</year>; <volume>31</volume>: <fpage>279</fpage>–<lpage>283</lpage>.</citation>
</ref>
<ref id="bibr184-0960327112456316">
<label>184</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Saliner</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Worth</surname>
<given-names>AP</given-names>
</name>
</person-group>. <comment>Institute IHCP Directorate General Joint Research Centre</comment>. <source>Testing strategies for the prediction of skin and eye irritation and corrosion for regulatory purposes</source>. <publisher-loc>Luxembourg</publisher-loc>: <publisher-name>Office for the Official Publications of the European Communities</publisher-name>, <year>2007</year>.</citation>
</ref>
<ref id="bibr185-0960327112456316">
<label>185</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Potts</surname>
<given-names>AM</given-names>
</name>
</person-group>. <article-title>Toxic responses of the eye</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Klaassen</surname>
<given-names>CD</given-names>
</name>
</person-group> (ed) <source>Casarett and Doull’s toxicology. The basic science of poisons</source>. <edition>5th ed</edition>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>McGraw–Hill</publisher-name>, <year>1996</year>, pp. <fpage>583</fpage>–<lpage>615</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>